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ABSTRACT 
The mental health of soldiers is a growing concern as rates of depression and 
suicide have increased in soldiers with recently more deaths attributed to suicide than 
deaths due to combat in Afghanistan in 2012.  Previous research has demonstrated the 
potential for eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), vitamin D, 
physical activity, and physical fitness to improve and arachidonic acid (AA) to threaten 
depression/quality of life scores.  This study examined whether blood fatty acid levels, 
vitamin D status and/or physical activity are associated with physical fitness scores, 
measures of mood, and measures of resiliency in active duty soldiers.  100 active duty 
males at Fort Hood, TX underwent a battery of psychometric tests, anthropometric, 
fitness tests, and donated fasting blood samples.  Pearson bivariate correlation analysis 
revealed significant correlations among psychometric tests, anthropometric, physical 
performance, reported physical inactivity (sitting time), and fatty acid and vitamin D 
blood levels. Categorical analysis revealed significant difference in levels of fatty acids 
and vitamin D, anthropometric, physical performance, and psychometric measures. 
Based on these findings, a regression equation was developed to predict a depressed 
mood status as determined by the Patient Health Questionnaire-9.  The equation 
accurately predicted 80% of our participants with a sensitivity of 76.9% and a specificity 
of 80.5%.   Results indicate that lack of physical activity and fitness, high levels of AA 
and low levels of EPA, DHA, and vitamin D could increase the risk of depressed mood 
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and that use of a regression equation may be helpful in identifying soldiers at higher risk 
for possible intervention. Future studies should evaluate the impact of exercise and diet 
interventions as a means of improving resiliency and reducing depressed mood in 
soldiers.  
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CHAPTER I 
INTRODUCTION AND RATIONALE 
Background 
The mental health of soldiers is a growing concern as rates of depression and 
suicide have increased in soldiers with recently more deaths attributed to suicide than 
deaths due to combat in Afghanistan in 2012 1.  Previous research has demonstrated the 
potential for eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), and 
cholecalciferol (Vitamin D), physical activity, and physical fitness to improve 
depression/quality of life scores.  The purpose of this study was to determine if 
EPA/DHA, vitamin D levels, and physical activity are associated with physical fitness 
scores, Patient Health Questionnaire-9 (PHQ-9), and Dispositional Resiliency Scale-15 
DRS-15 scores in active duty soldiers.  Higher DRS-15 scores have been associated with 
higher success in Special Forces Assessment and Selection (SFAS) an extremely 
arduous military selection program with a high attrition rate2 
Omega-3 fatty acids and vitamin D are also of particular interest in the military 
population as a study by Lewis et al. demonstrated that active duty military with the 
lowest DHA levels were 62% more likely to have committed suicide 3.  Umhau et al 
showed that 30% of the 900 samples taken from active duty soldiers between 2002-2008 
were vitamin D deficient 4.  Increased physical fitness has also been shown to reduce 
soldiers’ risk for depression 5.   This study examined the relationships between reported 
physical activity, physical performance, omega-3 and 6 fatty acids, vitamin D, and 
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measures of resiliency (DRS-15, Big 5) in active duty soldiers to determine if diet and/or 
physical activity patterns related to mood/depression scores (PHQ-9) and whether 
individuals with different levels or categories had differing responses among these 
variables. 
Statement of the Problem 
Does physical fitness and/or blood levels of EPA, DHA, and Vitamin D relate to 
measures of mood and resiliency in active duty soldiers? 
Purpose 
The purpose of this study was to determine if a relationship exists between 
omega-3, vitamin D, and physical activity levels and markers of mood and resiliency in 
active duty soldiers.   Additionally, to determine if individuals with different levels of 
fitness, Omega-3, and vitamin D status, and resiliency status are at different risk for 
mood disturbances.   If so, future studies could consider manipulating diet and/or activity 
levels as a means to improve soldier mood and reduce the risk for depression related 
problems.   
General Study Overview 
Approximately 100 apparently healthy active duty male soldiers age 18-50 years 
of age were recruited to participate in this study.  Soldiers were given the opportunity to 
attend a mass briefing in the Brigade classroom where they received a recruitment brief. 
Interested participants who met these general criteria were invited to a familiarization 
session in which the details of the study were explained, and human participants consent 
forms were signed.  Once consent forms were signed, participants completed a form with 
 3 
 
general information concerning their military area of specialty, time in service, rank, and 
number of deployments, and completed the International Physical Activity 
Questionnaire, Big 5 Personality, and DRS-15.   
Participants were instructed to fast for 8-10 hours only drinking water before 
testing on day 2 and notified of where to report the next day for the scheduled blood 
draw (Table 1).  For the 2nd day of testing, participants arrived for testing fasted and 
underwent a blood draw where 10 ml of blood was taken for plasma fatty acid and 
vitamin D analysis.  Participants were told to return in the next morning for the Army 
Physical Fitness Test (APFT). 
  On the third and final day of testing, participants arrived and received a 
instructions on the task, conditions, and standards for each event of the APFT.  
Participants completed 2 minutes of push-ups, 2 minutes of sit-ups, and a 2 mile run for 
time.  Participants were allowed 10 minutes of rest between each event. Number of 
repetitions completed and run times were recorded for each subject. Height and weight 
of each subject also were measured as per standard protocol of an APFT. Overview of 
the study, see Table 1 on page 25, and the consent form and data collection forms can be 
found in Appendices A through F.  
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Hypotheses 
H1: There is a significant relationship between depression scores (PHQ-9) and resiliency 
scores (DRS-15 and Big 5).  
H2: There is a significant relationship between resiliency scores and physical 
performance scores.  
H3: Blood fatty acid levels are significanlty associated with resiliency. 
H4: Sitting time is significantly associated with resiliency.  
H5: Higher resiliency scores will be significantly related with higher mood scores.  
H6: Lower Vitamin D levels will be significantly related with higher resiliency and 
physical performance scores. 
H7: Higher EPA levels are significantly associated with higher physical performance 
scores. 
H8: Lower EPA levels are significantly associated with lower resiliency scores.  
H9: Lower DHA is associated with lower physical performance scores. 
H10: Lower DHA levels are significantly associated with higher depression scores.   
H11: Higher AA levels is associated with lower physical performance. 
H12: Higher AA levels are significantly associated with higher depression scores.   
H13: Higher BMI category is associated with significantly lower physical fitness scores. 
H14: Higher BMI category is associated with higher depression scores.   
H15: Increased sitting time levels will be significantly associated with lower physical 
fitness scores. 
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H16: Increased sitting time levels will be significantly associated with higher depression 
scores.  
H17: Increased physical fitness will be significantly associated with higher resiliency 
scores 
H18: Increased physical fitness will be significantly associated with lower depression 
scores. 
Null Hypotheses 
H01: There will be no significant relationship between resiliency scores and number of 
deployments. 
Delimitations 
The study was conducted within the following parameters: 
1. Approximately 100 apparently healthy active duty male soldiers age 18-50 were
recruited to participate in this study 
2. Participants were recruited at a briefing at 1st Brigade Combat Team, 1st Cavalry
Division, Fort Hood Texas. 
3. Testing sessions were conducted at Fort Hood Texas.
4. Participants showed up at minimum 10 hours fasted for their blood draws on day 2.
Limitations 
1. All participants were recruited from the same Battalion at Fort, Hood Texas.
2. Due to no supplement intervention being utilized, only an associative relationship can
be established. 
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Assumptions 
1. Participants were honest in completing all questionnaires.  
2. Participants gave max effort on the Army Physical Fitness Test (APFT). 
3. The population is a normal distribution and an accurate representation of male soldiers 
in Battalion.  
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CHAPTER II 
REVIEW OF LITERATURE 
Mental Health and the Military 
Mental disorders are the leading cause of hospital bed days and the second 
leading cause of medical encounters for active component service members in the U.S. 
military6.  Between 2006 and 2012, the rate of PTSD in the active component of the 
military increased 192%, depression increased 66%, alcohol abuse and dependence 
increased 110%, and adjustment disorder increased 52%6. More than 300,000 new cases 
of mental health conditions occured among Operations Enduring Freedom and Iraqi 
Freedom (OEF/OIF) veterans between 2001 and 20077.  More recently a report by the 
Veteran’s Administration found suicide rates among male veterans under 30 increased 
by 44 % from 2009-20118   
In a analyses of active duty personnel serving from 2001 to 2006, Shen and 
colleagues9 reported that in 333,548 Army soldiers a deployment to Afghanistan or Iraq 
increased the odds of major depression by 3.52 times compared to Army soldiers who 
were deployed.  A reported mental health concern is combat experiences during 
deployment might increase a service members capacity for suicide10.  In a sample of 522 
service members deployed in support of Operation Iraqi Freedom (OIF) Bryan et al.10 
reported that a greater range of combat experience, measured by a Combat Experience 
Scale (CES), predicts acquired capability of suicide10.  However, a more recent and 
larger analyses by LeardMann et al11 of 151,560 active duty and Reserve/National Guard 
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with assessments in 2001, 2004, and 2007 found that combat experience, number of 
deployments, and length of deployment were not associated with increased suicide risk. 
In a study of 18,305 Army and National Guard soldiers, Thomas and associates12 
reported a depression rate, measured by PHQ-9, with no functional impairment of 16% 
at 3 months and 15.7% at 12 months for active Army, and 11.5% at 3 months and 15.9% 
for the National Guard Soldiers deployed to Iraq.  Breitbach et al.13 surveyed 955 male 
soldiers in Advanced Individual Training (AIT) and reported mean PHQ-9 scores of 
4.93±5.17 with 17.3% classified as having mild depression, 7.2% moderate depression, 
3.2% moderate-severe depression, and 4.6% having severe depression.   Luxton and 
colleagues14 analyzed pre-and post-deployment data from 6,427 military males and 
reported depression rates, as measured by PHQ-9, of 4.48% pre-deployment and 10.05% 
post-deployment.  Schaller and associates15 in a 53,073 soldier sample reported a PHQ-9 
adjusted mean of 7.2 in active service members, 6.7 in National Guard, and 6.5 in 
reservists, a deployment was not a significant risk factor for depression in active duty but 
it should be noted that this group included females and members from other services.  
Dispositional Resiliency Scale-15 and the Military 
Bartone states “Hardiness is a personality style associated with resilience, good 
health, and performance under stressful conditions”16  Special Forces Assessment and 
Selection is a high-stress course with a 45-55% attrition rate2. In a sample of 1,138 males 
going through Special Forces Assessment selection, Bartone and associates2 reported 
DRS-15 scores as a significant predictor (p<0.02) with every 1 point increase in DRS-15 
score translating to a 3.3% increase in odds of graduating.  Higher DRS-15 scores also 
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have been associated with lower PTSD scores. Escolas et al.,17 surveyed 561 service 
members who had been deployed for at least 30 days and found DRS-15 scores were 
negatively associated (r=-0.39; p<0.001) with PTSD scores measured by Post Traumatic 
Stress Disorder Checklist Military Version (PCL-M).  Higher resiliency scores also 
areassociated with improved physical as well as mental health. Taylor and colleagues18 
surveyed 120 military males using the DRS-15 and Short Form Health Survey (SF-36) 
and reported DRS-15 scores were associated with physical and mental health markers.  
The relationship between resiliency and health in the military population also has been 
demonstrated by blood markers (IL-6, IL-12, IL4, IL-10, and neuropeptide Y).  Sandvik 
and associates19 reported that fluctuations in the DRS-15 scoring high overall while 
scoring low in one of the subcomponents of commitment, control, and challenge leading 
to a “unbalanced” score were associated with  a less optimal immune and 
neuroendocrine response to stress in 21 Norwegian navy cadets during a high stress field 
exercise.  
Omega-3 Fatty Acids and Mental Health  
The evidence linking deficiencies in omega-3 fatty acids and psychiatric 
disorders were reviewed by the American Psychiatric Association (APA) in the 
treatment recommendations issued for omega-3 fatty acids in psychiatric patients20.  The 
APA found that low fish consumption or a low omega-3 body compositional status was 
associated with increased risk of depression and other affective illnesses. In support of 
this finding is the fact that prevalence rates of major depression are 50 times higher 
among countries with little seafood consumption compared to countries with the highest 
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consumption21. Three meta-analyses20, 22, 23  reported treatment effect sizes for omega-3 
fatty acids that are larger than those reported for most antidepressant pharmaceuticals.  
The APA recommends at least 1 gram/ day of EPA as concomitant therapy for most 
affective and psychotic disorders20. 
Epidemiologic data suggest that low fish consumption is a risk factor, although 
not a cause of depression and/or suicidal ideations.  In a study that examined 1,767 
participants in northern Finland reported that frequent fish consumption (twice per week 
or more) significantly reduced the risk of reporting depressive symptoms and of 
reporting suicidal thinking after adjustment for confounding variables24. A Belgium 
study reported that the seasonal variation in omega-3 plasma status closely correlated 
with the seasonal variation in suicide rates25. Lower fish consumption was associated 
with a doubling of the risk suicidal thinking by mothers during pregnancy, after control 
for 29 confounding variables in a longitudinal cohort study enrolling 14,541 
pregnancies26.  Lewis et al.3 in a study using 800 blood samples from service members 
who committed suicide compared to 800 non-suicide controls reported that the risk of 
being in the suicide group increased by 14% per every standard deviation reduction in 
DHA blood levels3 
A case-control study of 200 participants in Dalian, China, investigators found 
30% lower RBC concentrations of EPA among suicide attempters and a dose-response 
association between low EPA status and greater risk27. In a study following 33 
medication-free depressed participants over a two-year period found that participants 
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with lower DHA levels and higher omega-6 to omega-3 ratios had a significantly higher 
risk of attempting suicide28.  
A randomized blinded placebo controlled trial in Ireland investigators reported a 
45% reduction in suicidal thinking and a 30% reduction in depression among patients 
with recurrent self-harm recruited from an emergency room29.  This intervention used 
1.2 and 0.9 g/d of EPA and DHA respectively in a 12-week trial with 22 participants in 
the treatment group and 27 participants receiving the placebo.  Participants receiving the 
EPA and DHA treatment also reported a reduced perception of daily stresses and anxiety 
that is likely relevant to a reduction of risk of the development of PTSD29.   
However in a study involving 78 soldiers deployed to Iraq, researchers found the 
omega- index, obtained by combining EPA + DHA bloods levels, was not associated 
with scores for anxiety, depression, or sleep30. All of the soldiers used in this study had 
mild to moderate depression that could have impacted the relationship between omega-3 
levels and anxiety and depression scores.  The researchers did find that the omega-3 
index was associated with improved neurocognitive performance, particularly Cognitive 
Flexibility (CF) and Executive Function (EF) and the effect was seen most in the 81% 
soldiers who reported poor sleep30.  This finding supports the concept of omega-3 fatty 
acids being utilized as a tool to ameliorate the negative impacts of stress and sleep loss.  
The evidence for the potential for omega-3 fatty acids to treat depression was strong 
enough for the Department of Defense to fund a $10 million, 3 year study utilizing 
omega-3 fatty acids as treatment for veterans who had attempted suicide31.  Recently, 
three papers were published in the journal Military Medicine discussing the challenges 
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and methods of incorporating more omega-3 fatty acids into the military food supply 
chain32-34. 
Omega-3 Fatty Acids and Muscle Tissue 
Aside from cognitive benefits, fish oil also has demonstrated the potential to 
increase muscle hypertrophy and strength, both of which can be beneficial to the military 
population. In a study exploring insulin sensitivity and omega-3 fatty acids, six men and 
six women over the age of 60 were provided a 6-week isocaloric control diet, and then 
measurements of insulin sensitivity and inflammation were taken.  The participants then 
underwent an 8-week experimental diet that was supplemented with 720 grams of fatty 
fish weekly and 15ml of sardine oil daily.  The experimental diet significantly increased 
insulin sensitivity and lowered C-reactive protein35. 
The benefits of omega-3 fatty acids on skeletal muscle and plasma stress markers 
were further demonstrated in a population of 44 men and women (34± 13 years of age). 
Baseline measurements of body composition, resting metabolic rate, and salivary 
cortisol were taken.  The participants then were randomly assigned to receive either 4 
grams per day of safflower oil (control) or 4 grams per day of fish oil for six weeks at 
which time baseline measurements were repeated.  The fish oil group significantly 
gained more muscle mass, significantly reduced fat mass and demonstrated a tendency to 
decrease salivary cortisol levels36. 
Smith et al. randomly assigned sixteen healthy older adults to either receive 
omega-3 fatty acids or corn oil for eight weeks.  The rate of muscle protein synthesis 
was measured both pre- and post-supplementation during basal, post absorptive 
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conditions and during a hyperaminoacidemic-hyperinsulinemic clamp.  The corn oil 
group showed no increase in muscle protein or anabolic signaling across all testing.  The 
omega-3 group showed no increase in the basal rate of muscle protein synthesis before 
and after supplementation.  Howerever the omega-3 fatty acids provided a synergistic 
effect on muscle protein synthesis during the hyperaminoacidemia-hyperinsulinemia-
induced increase in muscle protein synthesis along with greater increases in anabolic 
signaling of muscle mTOR and p70s6k phosphorylation37. 
Smith et al.37 also conducted a similar study on a younger population of nine 
adults 25-45 years of age to ensure that the muscle growth effects of omega-3 fatty acids 
did not just occur in the elderly.  The participants were provided four grams per day of 
omega-3s in the form of Lovaza® for eight weeks.  Muscle protein synthesis and 
mTOR-p70s6k pathway were measured during basal, post absorptive conditions, and 
during a hyperinsulinemic-hyperaminoacidemic clamp.  While neither protein synthesis 
nor mTOR-p70sk pathway signaling increased during the basal testing, both did 
significantly increase after insulin amino acid infusion38.  The study validated the 
previous findings using elderly participants but also demonstrated that the same 
increases in muscle protein synthesis and mTOR-p70sk occur in younger healthy 
population. 
Omega-3 fatty acids also have the ability to improve measures of strength.  A 
study of 45 women (64±1.4 years of age) who were randomly assigned to three groups.  
One group strength-trained for 90 days, one group strength trained and received two 
grams per day of fish oil for 90 days, and one group received strength trained and 
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received fish oil at two grams/day for 120 days and initiated fish oil supplementation 60 
days prior to training.  Peak torque and torque rate were calculated based on the force of 
the participants’ isometric contraction using a strain gauge and multiplied by the 
distance from the attachment point to the segment joint center.  Peak torque and torque 
rate improved for all groups but the fish oil groups gained more strength than then the 
strength-training only group and performed better in the functional task of chair-rising 
compared to the strength training only group39. 
Omega-3 fatty acids also have demonstrated anti-catabolic properties. A recent 
study showed that in vivo omega-3 fatty acids increased protein synthesis by 25% 
compared to control muscle cells of ageing rats and when cells were induced into a 
starvation state, EPA reduced protein breakdown by 22% compared to the control40.  
This study demonstrated that omega-3 fatty acids have the potential to be anti-catabolic 
during periods of caloric restriction. The ability to spare muscle during caloric restriction 
would make omega-3 fatty acids beneficial in high-stress military scenarios where food 
might not be optimal. 
Vitamin D and Mental Health  
Researchers also have demonstrated an association between vitamin D and 
mental health.  In a cross-sectional study of 12,594 participants lasting four years, lower 
vitamin D levels were associated with depressive indicators, especially in those with a 
history of depression41.   A study in the Netherlands involving 494 participants with no 
history of depression (controls), 790 participants with a history of a depressive episode 
requiring treatment, and 1,102 participants currently being treated for depression found 
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that those currently being treated for depression had a significant lower level of plasma 
vitamin D compared to the control42.  The authors also reported an inverse relationship 
between vitamin D levels and depression severity in those being treated for depression42.  
Ganji et al.43 reported that in a sample of 7,970 non-institutionalized US residents aged 
15-39 the odds ratio for having current depressive episodes was 1.85 (p=0.021) in those 
who were vitamin D deficient compared to those who were not. 
Given the strong link between depression and vitamin D levels, researchers have 
conducted intervention trials to determine if a cause and effect relationship exists. 
A Norwegian study involving 441 participants supplemented with either a placebo, 
20,000 IU, or 40,000 IU of vitamin D for one year reported that in the two groups 
receiving vitamin D, but not the placebo, there was a significant improvement in Beck 
Depression Inventory Scores44.  Similarly, researchers in Sweden found that low levels 
of vitamin D were associated with depression in adolescents and supplementation 
attenuated symptoms of depression and improved measures of well-being45. 
This research demonstrates that supplemental vitamin D might serve as an 
intervention to combat depression. However, the depression-ameliorating impact of 
vitamin D has not always been demonstrated in research.  In a study involving 230 
participants with low vitamin D and 114 participants with high vitamin D as nested 
controls reported that in low vitamin D participants no difference was found in 
depression scores in those receiving 40,000 IU of vitamin D3 weekly versus the 
placebo46.  Given the question of effectiveness of vitamin D supplementation on 
depression, the cause and effect relationship needs to be further explored.  Specifically, 
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in the military population, Umhau and colleagues4 compared 495 blood samples of 
service members who committed suicide versus 495 control service members and found 
that subjects in the lowest octile of vitamin D blood levels had the highest risk of being 
in the suicide group.  Another key finding was more than 30% of all 900 samples were 
vitamin D deficient4.  In a study of 314 Special Operation Forces (SOF) personnel, 
Wentz et al.47 reported that 50% of the participants were either vitamin D deficient or 
insufficient.  Based on these studies, adequate vitamin D levels in service members 
should be a concern.  
Vitamin D and Muscle Tissue 
Vitamin D has long been associated with attaining adequate sun exposure. In the 
military population, where much of the skin is covered due to uniform and equipment 
requirements (i.e., body armor), sunshine exposure cannot be used as a reliable source of 
vitamin D.  Thus,  as discussed earlier , a 30% decreased rate of vitamin D had been 
previously observed in this population 4.   This can have detrimental effects on health 
and bone metabolism as well as muscle growth and strength.  
Moreira-Pfrimer et al., conducted a double-blind, placebo-controlled, randomized 
trial of institutionalized people 60 years of age or older receiving either a 
calcium/placebo combination or a calcium/vitamin D combination for 6 months.  
Vitamin D and muscle strength tests were conducted pre-and post-6 month 
supplementation.  As expected, the vitamin D group had significantly increased plasma 
vitamin D levels compared to the placebo group.  However, despite no strength training 
protocol, the vitamin D group increased hip flexor strength by 16.4% and knee extensor 
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strength by 24.6% while no increase in strength was seen in the calcium/placebo group48.  
It is important to point out that both groups received sun exposure as plasma vitamin D 
concetrattions (December-May) significantly increased in both groups as the study went 
into the summer months, also the study was conducted  in Sao Paulo, Brazil.  The 
finding that strength increased in the supplement group despite the seasonal increase in 
plasma vitamin D in both groups suggests the supplemental vitamin D was acting as an 
ergogenic rather than just treating a vitamin D deficiency in the experimental group. 
Wicherts et al. examined the association of serum vitamin D concentration with 
currently physical performance and its decline over three years among the elderly.  The 
study consisted of 1,234 men and women aged 65 years and older and 979 for the 
longitudinal analysis.  Physical performance was measured by a walking test, chair 
stands, and tandem stands49.  The analysis adjusted for age, gender, chronic diseases, and 
degree of urbanization, body mass index, and alcohol consumption.  Serum vitamin D 
concentrations below 20 ng/ml were associated with poorer initial physical performance 
and a greater decline in physical performance over the next three years49.  Also of 
significance was that 50% of the group tested had concentrations of 20 ng/ml or below, 
demonstrating that a vitamin D intervention would be beneficial in this population. 
Researchers also have demonstrated vitamin D provides similar benefits in terms 
of muscular hypertrophy and strength in younger individuals.  Researchers investigated 
vitamin D levels and the degree of muscle fat infiltration in 90 post-pubertal females 16-
22 years of age living in California.  Women with sufficient vitamin D levels had 
significantly lower muscle fat than women with insufficient and deficient levels of 
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vitamin D.  The finding was independent of body mass50.  The researchers also found 
that 59% of the participants were vitamin D insufficient (<29 ng/ml) and 24% of that 
sample was clinically deficient (< 20 ng/ml)50.  Koundourakis and associates51 reported 
that in 67 male soccer players in Greece, vitamin D concentrations were significantly 
correlated pre-training program with squat jump (r=0.731, p=<0.001) counter movement 
jump (r=0.740, p=<0.001), 10 meter sprint, (r=-0.648, p=<0.001)  20 meter sprint (r=-
0.673, p=<0.001), and peak VO2 (r=0.43, p=<0.001).  Vitamin D concentration remained 
significantly correlated post-training with squat jump (r=0.591, p=<0.001) counter 
movement jump (r=0.476, p=<0.001), 10 meter sprint, (r=-0.410, p=<0.001) 20 meter 
sprint (r=-0.426, p=<0.001), and peak VO2 (r=0.394, p=0.006) and the end of a 6 week 
off-season training program. 
Androgen levels are associated with both muscle size and strength, Wehr et al.52 
looked at the association of vitamin D concetration with testosterone, a free androgen 
index (FAI), and steroid hormone-binding globulin (SHBG) in 2,299 men during routine 
coronary angiography between 1997-2000.  The study revealed men with adequate 
vitamin D concentrations (>30ng/ml) had significantly higher levels of testosterone and 
FAI and significantly lower concetration of SHBG compared to insufficient (20-29.9 
ng/ml) vitamin D men and deficient (<20ng/ml) vitamin D men52.  The researchers also 
found that testosterone concentrations followed seasonal variations with March having 
the lowest concentrations for all groups and August having the peak concentrations for 
all groups.  The study clearly demonstrated a relationship between vitamin D levels and 
androgen levels in men and the potential benefits if one were to supplement 
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insufficiencies/deficiencies and during winter seasons when less sun exposure is 
expected. 
The association of vitamin D and muscle strength were explored by Grimaldi et 
al.53 in 419 healthy men and women 20-76 years of age.  The strength measurements 
consisted of isometric and isokinetic strength in both the arms (dominant hand strength 
and elbow flexion and extension) and legs (dominant knee flexion and extension) using 
computerized dynamometry.  Age, gender, systolic blood pressure, diastolic blood 
pressure, resting heart rate, body mass index, physical activity counts, maximal oxygen 
uptake, and seasonal vitamin D concentrations were controlled for using multivariate 
models53. Vitamin D concentrations were associated with both arm and leg strength 
when controlling for age and gender.  However, when all areas were controlled vitamin 
D concentrations were not associated with isokinetic leg strength but were associated 
with isokinetic and isometric arm strength and isometric leg strength53.  The study 
clearly demonstrates the importance of vitamin D for muscle strength in adults and 
supports the notion that adequate vitamin D intake either via sunshine, food, and/or 
supplementation is beneficial for muscle strength. 
Two reviews on vitamin D and skeletal muscle supported the previous research 
findings with vitamin D being associated with optimal muscle function and improving 
muscle strength and function in individuals deficient regardless of strength training54, 55.  
Both papers supported the existence of a vitamin D receptor (VDR) in the skeletal 
muscle.  In animal models where VDR is not present, muscle fibers are 20% smaller in 
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diameter and more variable demonstrating that vitamin D has both genomic and non-
genomic influence on skeletal muscle54, 55.  
Body Mass Index and Mental Health 
A U.S. Department of Defense survey by Kress et al.56 of 10,040 service 
members found obesity, as classified by BMI, increased the odds of depressive 
symptoms compared to normal weight service members. Kress et al.56 reported 37% of 
the population was normal, 53% was overweight, and 10% was obese in the 7,567 active 
duty men in the 10,040 service members in the study.  In a secondary analyses of 15,915 
service members from a 2005 Department of Defense survey, Smith and associates57 
reported that among active duty military men, being obese was significantly associated 
with generalized anxiety disorder (GAD) symptoms (OR: 1.3, 95% CI: 1.02-1.77; p < 
.05) and being overweight was associated with serious psychological distress (SPD) 
symptoms (OR: 1.3, 95% CI: 1.05-1.71; p < .05). 
However, in a study of 7,514 U.S. service members receiving psychiatric care 
and 85,940 healthy service members serving as controls, Wyatt et al.,58 reported no 
relationship between BMI and psychiatric disorder.  The reason for this contradiction is 
probably best explained by de Wit59 and associates who reported the BMI and 
depression are not a linear association but rather describes a U-shaped curve.  A sample 
of 43,534 subjects age 18 to 99 in a general population was used to test the U-shaped 
curve and the authors found a very significant (p≤ 0.001) U-shaped association between 
BMI categories underweight, normal, overweight, and obese and depression, but no 
significant association between depression and continuous BMI59. 
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Physical Fitness and Mental Health 
Increased physical fitness and physical leisure time activities are associated with 
higher health-related quality of life scores in military age men in Finland60.  Vallance 
and colleagues61 reported increasing physical activity and decreasing sedentary time 
lowered the odds of depression is a cross-sectional study of 2,862 adults61     
Higher level of cardiorespiratory fitness is associated with increased health-
related quality of life scores in US Navy personnel62.  Poor cardiorespiratory fitness at 
18 years of age has been shown as a risk factor for depression in adulthood in 1,117,292 
Swedish military conscripts who were tracked for a period of 3 to 40 years63.  Army 
trainees who failed a physical fitness test were at increased risk of being diagnosed with 
a mental disorder in their first year of service64. Davidson and associates65 investigated  
346 Veterans being treated for PTSD, that exercise was associated with fewer depressive 
symptoms along with better quality of sleep.  Two Bosnian studies of 100 and 141 
patients surveyed at a family medicine clinic using the IPAQ and PHQ-9 reported that an 
a association between higher physical activity and lower PHQ-9 stores and lower 
physical activity and higher PHQ-9 scores66, 67.  A thorough meta-analysis of 30 trials by 
Rimer et al..68  reported that exercise may serve as a potential treatment for depression, 
as exercise reduced depressive symptoms in depressed individuals when compared to no 
exercise68 
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Conclusion 
Based on these previous findings, a relationship between physical fitness, 
vitamin D, omega-3 fatty acids, and mental and physical performance was established.  
Given that the previous reported research has only observed these variables individually, 
our experiment combines the variables to determine if we can achieve a stronger 
relationship in our population.  Depending on the strength and existence of this 
relationship, a model might be developed to predict a soldier's mood more accurately 
based on this relationship.  
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CHAPTER III 
METHODS 
Participants 
100 apparently healthy active-duty male soldiers from a support Battalion at Fort 
Hood, Texas ages of 18 to 50 were recruited to participate in this study.  Inclusion 
criteria were not currently being treated by Behavioral Health and physically able to take 
the standard Army Physical Fitness Test (APFT).  Exclusion criteria were currently 
being treated by Behavioral Health and not physically capable of taking a standard 
APFT.  Interested participants who met these specific criteria were invited to a 
familiarization session in which the details of the study were explained. Participants 
signed consent forms in compliance with the Human Subjects Internal Review 
Committee at Texas A&M University and the Brooke Army Medical Center Department 
of Clinical Investigation Office of the Institutional Review Board.  
Study  
Recruitment and testing took place in the Troop area of 1st Brigade Combat 
Team, 1st Cavalry Division, Fort Hood, Texas. Blood samples were analyzed by Quest 
Diagnostics (Quest Diagnostics, Houston TX). Data analysis was conducted at the 
Exercise & Sport Nutrition Lab at Texas A&M University. 
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Experimental Design 
Participant recruitment and data collection were conducted over a 3-day period 
during the fall (Table 1).  On day 1, participants were recruited from the support 
Battalion.  Interested soldiers were given the opportunity to attend a mass briefing in the 
Brigade classroom where they received a recruitment brief.  Participants who met the 
inclusion criteria for the study were invited to a familiarization session in which the 
details of the study were explained, and human participants consent forms were signed.  
Once consent forms were signed, participants completed the IPAQ, PHQ-9, DRS-15, 
and Big 5 questionnaire along with general information concerning their military area of 
specialty, time in service, rank, and number of deployments completed.  The participants 
were instructed to fast for 8-10 hours with water being the only fluid allowed to be 
consumed.   Participants were notified of the location of the blood draw for day 2.  
On day 2, participants arrived for testing fasted and 10 ml of venous blood was 
obtained from an antecubital vein using standard phlebotomy procedures by a military 
medical staff member.  Participants were instructed to report to standardized road course 
the next morning for the APFT.  
On day 3 participants, received a brief on the task, conditions, and standards for 
each event of the APFT.  Participants completed 2 minutes of push ups, 2 minutes of sit 
ups, and a 2 mile run for time using standard military APFT procedures.  Participants 
were allowed 10 minutes of rest between each event.  The number of repetitions 
completed and run times was recorded for each subject.  Anthropometric measurements 
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of height and weight were taken for each participant, which is standard procedure for 
each APFT. Consent and data collection forms are found in Appendices A through F. 
Table 1: Study Overview 
Day 1 Day 2 Day 3 
Recruitment Brief 
Consent Form 
Background Information 
IPAQ 
DRS-15 
Big 5 
Blood Draw 
Informed of time and 
location of APFT 
APFT 
Height and weight 
recorded 
Medical Monitoring 
Medical surveillance was provided during all testing sessions.  At least two medics 
and a physician were present at all testing sessions.  No adverse events were reported during 
the APFT assessments.  Three participants screened reporting thoughts of self-harm based 
on data obtained in the PHQ-9.   Based on established protocol, the Brigade Surgeon was 
notified of the participant numbers and provided the participants with referrals and the 
participants were screened by Behavioral Health Care and deemed not to be a threat to 
themselves or others.  Since individuals were not actively in treatment at the time of testing 
data were included for analysis.  
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Methods and Procedures 
Plasma Omega-3 and Omega-6 Fatty Acids, Plasma 
Subject blood samples were analyzed by Quest Diagnostics (Quest Diagnostics, 
Houston, TX) assay extracts saturated and unsaturated fatty acids with chain lengths of 
between 14 and 24 carbons (C14:0-C24:1, for a total of 19 fatty acids) were isolated 
from plasma phospholipids. The phospholipids are isolated from the plasma using a solid 
phase extraction, hydrolyzed to release the fatty acids and then extracted by a liquid-
liquid extraction.  The fatty acids are then separated by HPLC, and detected by mass 
spectrometry (SIM or single ion monitoring and SRM or selective reaction monitoring) 
in the negative APCI mode.  Results are based on peak areas, with each individual fatty 
acid divided by the total fatty acid areas to generate a percentage. 
Calculation of ratios were made the following ways: Omega-3 index = 
(eicosapentaenoic acid + docosahexaenoic acid) ÷ total phospholipid fatty acids, omega-
6/omega-3 = sum of 6 omega-6 fatty acids ÷ sum of 4 omega-3 fatty acids and 
Arachidonic acid/Eicosapentaenoic acid = % Arachidonic acid ÷ % Eicosapentaenoic 
acid.  Omega-3 index categorical definitions for cardiovascular risk factor are omega-3 
index <1.1 High risk, omega-3 index 1.1-3.3 Moderate risk, and omega-3 index >3.3 
Low risk as established by previous research69-72.   The coefficient of variation for the 
omega-3 and omeg-6 testing is 10%.  The analytical sensitivity for omega-3 is 0.16%, 
omega-6 is 0.44%, arachidonic acid is 0.06%, eicosapentaenoic acid is 0.05%, and 
docosahexaenoic acid is 0.11%.  
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Vitamin D / 25 (OH) D 
Participant blood samples were analyzed by Quest Diagnostics (Quest 
Diagnostics, Houston, TX).  Protein precipitation of serum samples is used to release 
25OH vitamin D2 and D3 from their binding proteins.  Add this time the internal 
standards (deuterated 25OH D2 and D3) are added to correct for procedural losses.  The 
25OH D2 and D3 are separated from one another and other vitamin D analogs are 
separated by HPLC before being quantitated using a tandem MS analyzer run in positive 
mode.  The area under the peak of the anaylte and the respective internal standard are 
used in the final quantitation using a standard curve run in the same assay 25 (OH) D 
levels.   The test has an analytical sensitivity of 4 ng/mL for 25OHD2 and 25OHD3 and 
coefficient of variation of 5.8% 
Army Physical Fitness Test (APFT): 
The APFT provides a measure of upper and lower body muscular endurance. It is 
a performance test that indicates a soldier’s ability to perform physically and handle his 
or her own body weight. The APFT consists of two minutes of push ups, two minutes of 
sit ups, and a 2-mile run—done in that order—on the same day. Soldiers are allowed a 
minimum of 10 minutes and a maximum of 20 minutes rest between events. All three 
events must be completed within 2 hours. The test period is defined as the period of time 
that elapses from the start to the finish of the three events (from the first push-up 
performed to the last Soldier crossing the finish line of the 2-mile run event)73.  
 For the push up event, participants assumed the push up position on the 
command “Get Set” by placing their hands where they were comfortable for the 
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individual. Participants’ feet were allowed to be together or up to 12 inches apart. 
Participants body, when viewed from the side had to form a generally a straight line 
from their shoulders to their ankles. Participants were instructed to begin the push up 
event on the command “Go”.   Participants were instructed that a push-up consists of 
bending their elbows and lowering their entire body until their upper arms were parallel 
to the ground and returning to the starting position by raising their entire body until their 
arms were fully extended. Their body had to remain in a generally straight line and move 
as a unit for the entire repetition. At the end of each repetition, the scorer stated how 
many repetitions the participant correctly completed.  
If the participant failed to keep their body in a generally straight line, or lower 
their entire body until the upper arms extend parallel to the ground, or to extend their 
arms completely, then that repetition did not count. The scorer repeated the number of 
the participant’s last correct repetition until another good repetition was performed. If 
the participant rested on the ground or raised either hand or either foot from the ground, 
the event was terminated.   
For the sit ups participants were instructed to assume the starting position by lying 
on their back with their knees bent so that the upper and lower part of their legs form a 
90-degree angle. Participants were allowed to keep feet together or up to 12 inches apart 
while another participant held their ankles with their hands only. Participants were 
instructed no other bracing method could be utilized.  The participants were informed 
the heel was the only portion of the foot that must remain in contact with the ground.  
Participants were instructed to interlock their fingers behind their head, and the backs of 
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their hands must touch the ground before starting on the command of “Get Set”. On the 
command “Go” participants had to sit up to the vertical position were the base of their 
neck was directly above the base of their spine. Once the participants reached or 
surpassed the vertical position, they had to lower their body until the bottoms of both 
shoulder blades touched the ground to complete one repetition. Participants had to keep 
fingers interlocked behind their head and may not arch or bow their back or raise their 
glutes off the ground. Participants’ knees could not exceed a 90-degree angle. If 
participants broke any one or more of these rules, then the repetition did not count.  
For the 2-mile run participants were instructed on the command “Go” to run a flat 
standardized 2-mile run route as fast as possible.  Participants were instructed they could 
neither provide nor receive assistance during the run.  The time started on the command 
“Go” and time stopped when the participant crossed the marked finish line.  
Army Physical Fitness Test standards are adjusted for age, and physiological 
differences between the genders and score are based on established normative data74.  
Anthropometric Measurements 
Height was measured using a height rod on a Detecto 439 Physician Balance 
Beam Scale (Detecto Scale Company, Webb City, MO) and recorded to the nearest half 
inch.  Total body weight was also measured using a Detecto 439 Physician Balance 
Beam Scale (Detecto Scale Company, Webb City, MO) and recorded to the nearest half 
pound.  Body Mass Index (BMI) was then calculated by dividing weight in pounds by 
height in inches squared and multiplying by a conversion factor of 703 and classified as 
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either Normal BMI 18.5– 24, Overweight BMI 25.0-29.9, or Obese BMI 30 and above 
as per guidelines by the National Heart, Lung, and Blood Institute75.   
Patient Health Questionnaire-9 (PHQ9) 
PHQ-9 is an established valid reference for mood/depression with an established 
reliability and validity76-78.  The PHQ-9 is particularly useful in this non-clinical population 
for its ability to detect subthreshold depression in a general population76.  The different 
scoring cutoff points for the PHQ-9 is 5, 10, 15, and 20 for mild, moderate, moderate-severe, 
and severe depression respectively.  A score of ≥10 was used to classify participants as 
recommend for treatment of depression (major depression), which has been previously 
validated with a sensitivity and specificity of 88% when compared to structured interviews 
of patients by a mental health professional77. 
Dispositional Resiliency Scale-15 (DRS-15)  
The DRS-15 is a measure of hardiness and has been used and validated in civilian 
populations, military cadets, and soldiers going through Special Forces Assessment and 
Selection (SFAS) as a measurement of mental resiliency2, 16.  The test gives the individual a 
total resiliency score based on a 15 question, 45-point survey assessing commitment, 
control, and challenge each with a five-item subscale.  The DRS-15 has a high reliability 
with an established test-retest coefficient of .78 and respective subscale category  
coefficients of Commitment = .75, Control = .58, and Challenge = .8116. 
The Big 5 Personality Questionnaire  
The Big 5 Personality is  questionnaire is used to assess Neuroticism, Extraversion, 
Openness, Agreeableness, and Conscientiousness79.  A cluster analysis was used by a 
31 
psychologist to classify participants into three groups: resilient, undercontrolled, and 
overcontrolled. Based on the cluster analysis participants were coded either resilient or non-
resilient.  
International Physical Activity Questionnaire (IPAQ) 
Physical activity patterns were assessed using the IPAQ-Long Form that is the 
seven day version of the IPAQ. The IPAQ-Long Form assess the intensity(vigorous or 
moderate) and frequency of activities for job-related physical activity, transportation 
physical activity, housework, house maintenance, caring for family, recreation, sport, 
and leisure time physical activity.  The IPAQ-Long Form also assesses weekly time 
spent sitting.    The IPAQ is considered a reliable and valid measure of self-reported 
physical activity with Booth et al.80 reporting a correlation coefficient of 0.84 in the 
English short form of accelerometer data in participants from the United States.80, 81.  
The IPAQ has been reported to significantly overestimate activity82. 
Statistical Methods 
Pearson Product Moment Correlation was run to determine if a significant 
relationship existed between variables.  Variables with significant correlations were 
further analyzed by categorizing responses and analyzing them by Multivariate Analysis 
of Variance (MANOVA).   The Wilks’ Lambda p-level was used to determine the 
overall significance among the variables analyzed.  Univariate ANOVA with Least 
Squares Difference (LSD) post-hoc analysis was used to determine differences among 
categories for each variable.  Based on MANOVA results, a binary logistic regression 
model was constructed in order to predict mood outcomes.  Hosmer-Lemeshow test was 
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used to assess goodness of fit.  All analyses were completed us IBM SPSS statistics 
software version 22 (IBM Statistics, Chicago, IL).  
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CHAPTER IV 
RESULTS 
Participant Demographics 
Table 1 population data presents the means ± standard deviations and range of 
the participants on variables measured.  Participants were active duty male service 
members 26±5.6 years; 69.2±3.2 inches, 185±26 pounds, and had a BMI of 27.1±3.2 
kg/m2.  A total of 24 participants were classified as normal BMI between (18.5-24.9 
kg/m2), 57 were classified as overweight BMI (25-29.9 kg/m2), and 19 were classified as 
obese (>30 kg/m2).  Participants were in the service an average of 5.4±7.7 years (range 
six months to 22 years).   Out of the 100 participants studied, 37 had never deployed, 35 
deployed once, 11 had deployed twice, 7 had deployed three times, 8 had deployed 4 
times, one deployed 5 times, and one deployed 7 times.  Ten of the participants were 
officers, 26 of the participants were Non-Commissioned Officers, and the remaining 64 
participants were lower enlisted E-4 and below.    
Fitness Assessment 
Table 2 shows that the participants performed means ± standard deviations and 
range for push-ups 56±13.8 (69) in 2 minutes, 63±11.3 sit-ups (69) in 2 minutes, and ran 
two miles in 959.68±167.37 (1140) seconds.  Raw results were scored on a 100-point 
scale based on Army Field Manual 7-2273 that takes into account age and sex of the 
individual.  The mean±SD for push-ups score was 77.8±13.7, sit-ups score was  
 34 
 
   Table 2.  Population Data. 
Variables Mean±SD Range Variables  Mean±SD Range 
Age (yrs) 26±5.6 22 PHQ-9 Score  4.93±5.17 24 
Height (in) 69.2±3.2 16 Commitment  9.57±3.2 14 
Weight (lbs) 185±26 121 Control  12.22±3.0 15 
BMI (kg/m2) 27.1±3.2 15.68 Challenge  8.70±3.3 15 
Service (yrs) 5.4±7.7 21.5 DRS-15 Score  30.5±6.7 41 
Deployments 1.22±1.40 7 N-6 to N-3 Ratio  8.41±3.25 31.30 
Push-ups(Reps) 56±13.8 69 Sitting Time (min/wk)  2,226±1,506 12,410 
Push-up Score 77.8±13.7 53 Vit D (ng/mL)  28.6±8.7 50 
Sit-ups(Reps) 63±11.3 67 N-3 Index (EPA + DHA)  1.38±.51 3.30 
Sit-up Score 77.5±14.0 69 EPA (% total phospholipids)   0.205±0.16 1.10 
Run time (sec) 957±167 1140 DHA (% total 
phospholipids) 
 1.17±0.43 2.50 
Run Score 66.6±20.7 77 AA (% total phospholipids)   0.206±0.07 0.30 
APFT score 225.6±34.6 178     
Data are depicted as means ± SD 
 
 
77.5±14.0, and run score 66.6±20.7.  Scoring is based on a scale of 100 established on 
prior normative data74.  A score less than 60 in anyone event is considered failing. 
Psychometric Assessments 
Table 2 shows or the Patient Health Questionnaire-9 (PHQ), the mean and 
standard deviation was 4.93±5.17 with 63 participants classified as minimal depression 
(0-4), 24 participants classify as mildly depressed (score of 5-9), 7 participants classified 
as moderately depressed (10-14), 1 subject classified as moderately severe depressed 
(15-19), and 5 participants classify as severely depressed (20-24).  The one subject 
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classified as moderately severe was moved into the severely depressed category based 
on the score for MANOVA analysis.  In terms of the Dispositional Resiliency Scale-15 
(DRS-15), the score for commitment was 9.57±3.2, control was 12.22±3.0, challenge 
was 8.70±3.3, and total hardiness/resiliency was 30.50±6.69.    
Physical Activity  
Participants appeared to be confused by the activity questions on the IPAQ and 
either included or excluded work activity in their physical activity report given the MET 
total mean±SD was 21,958±81,577 MET-minutes/week.  Given the high standard 
deviation and the fact that 32 participants did not report any job activity, we deemed the 
MET data invalid and did not use it in our analyses.  However, all participants did report 
sitting time, so data were used in following analyses. In table 1 total sitting per week of 
2,226±1,506 (12,410) minutes per week.   
Hematological Analysis 
Table 2 contains the mean and range of vitamin D was 28.6±8.7 (50) ng/mL with 
16 of the participants classified as deficient (<20ng/mL), 39 as insufficient (20-
30ng/mL), and 45 as optimal (≥30ng/mL).  The definition of vitamin D deficiency and 
insufficiency is based on the practice guidelines of  The Endocrine Society defined as a 
25(OH)D below 20 ng/ml (50 nmol/liter), and vitamin D insufficiency as a 25(OH)D of 
21–29 ng/ml (525–725 nmol/liter) 83.   It should be noted that this definition differs from 
the Institute Of  Medicine concentration of 16 ng/ml (40 nmol/liter) which meet the 
requirements of approximately half the population, and levels of 20 ng/ml (50 nmol/liter) 
cover the requirements of at least 97.5% of the population 84.  There has been a debate 
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by both Institute of Medicine and The Endocrine Society over the differing 
recommendations85, 86. 
The mean for Omega-3 Index was 1.38±.51 with 19 participants classified at 
high risk for cardiovascular disease, 80 for moderate risk, and only 1 classify in the low-
risk category.  The mean and range for EPA was 0.205±0.159 (1.10) percent of total 
blood phospholipids.   The mean DHA level was 1.17±0.426 (2.50) percent of total 
blood phospholipids. The mean and range AA level observed was 0.206±0.07 (0.30) 
while the mean omega-6 to omega-3 ratio was 8.41±3.25 (31.30) 
Correlational Analysis  
Table 3 is the Pearson correlation between all variables with ** denoting 
variables that are statistically significant at p≤0.05 and * denoting variables significant at 
p ≤0.01.  There was no significant relationship between number of deployments and 
resiliency scores so we accept the null hypotheses H01: There will be no significant 
relationship between resiliency scores and number of deployments. 
PHQ-9 scores were significantly correlated with DRS total resiliency scores (r=-
0.533, p≤0.05), Big 5 resiliency (r=-0.301, p≤0.05), and run time (r=-0.269, p≤0.05).  
Because DRS total resiliency scores had a higher r-value, it was chosen as the 
psychometric test to be used in further analyses.   Based on our findings we accept H1: 
There is a significant relationship between depression scores (PHQ-9) and resiliency 
scores (DRS-15 and Big 5).  DRS total resiliency scores were positively correlated with 
run scores (r=0.232, p≤0.05) and negatively associated with weekly sitting time (r=-
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0.202, p≤0.01).  Based on our findings we accept H2: There is a significant relationship 
between resiliency scores and physical performance scores. 
DRS total resiliency scores were correlated with arachidonic acid levels (r=-0.205, 
p≤0.01).  Run scores were significantly correlated with Body Mass Index (r=-0.200, 
p≤0.05), number of push-ups (r=.415, p≤0.05), push-up score (r=.406, p≤0.05), number 
of sit-ups (r=.464, p≤0.05), sit-up score (r=.463, p≤0.05), and DRS commitment (-.198, 
p≤0.05). Vitamin D levels were associated weekly sitting time (r=-221, p≤0.05).  EPA 
levels were significantly associated with number of push-ups (r=.262, p≤0.05) and sit-
ups (.257, p≤0.05).  DHA levels were significantly associated with number of push-ups 
(.209, p≤0.05). Arachidonic Acid levels were associated with DRS total resiliency (r=-
.205, p≤0.05).  Weekly sitting totals were also significantly correlated with DRS 
Commitment (r=-.312, p≤0.05). Based on our findings we accept H3: Blood fatty acid 
levels are significantly associated with resiliency and H4: Sitting time is significantly 
associated with resiliency.  
 
  
 38 
 
Table 3.  Pearson Correlation of Variables 
 Agea Htb Wtc BMId Depe PUf PU Sg SUh SU Si R Tj Rn Sk APFT l Vit Dm 
Agea 1 0.112 0.183 0.120 0.507** 0.117 0.156 -0.007 0.179 -0.002 0.381** 0.280** -0.001 
Htb 0.112 1 0.542** -0.150 -0.049 -0.149 -0.129 -0.040 0.056 0.024 0.107 0.057 0.119 
Wtc 0.183 0.542** 1 0.745** 0.124 -0.083 -.0036 -0.274** -0.173 0.145 -0.099 -0.104 -0.049 
BMId 0.120 -0.150 0.745** 1 0.185 0.022 0.063 -0.280** -0.242* 0.148 -0.200* -0.164 -0.150 
Depe 0.507** -0.049 0.124 0.185 1 0.128 0.173 0.015 0.075 0.058 0.199* 0.183 0.140 
PUf 0.117 -0.149 -0.083 0.022 0.128 1 0.970** 0.574** 0.400** -0.221* 0.415** 0.707** 0.005 
PU Sg 0.156 -0.129 -0.036 0.063 0.173 0.970** 1 0.523** 0.397** -0.174 0.406** 0.710** 0.011 
SUh -0.007 -0.040 -0.274** -0.280** 0.015 0.574** 0.523** 1 0.836** -0.279** 0.464** 0.726** 0.037 
SU Si 0.179 0.056 -0.173 -0.242* 0.075 0.400** 0.397** 0.836** 1 -0.213* 0.463** 0.737** 0.000 
R Tj -0.002 0.024 0.145 0.148 0.058 -0.221* -0.174 -0.279** -0.213* 1 -0.587** -0.272** -0.019 
Rn Sk 0.381** 0.107 -0.099 -0.200* 0.199* 0.415** 0.406** 0.464** 0.463** -0.587** 1 0.801** 0.077 
APFT l 0.280** 0.057 -0.104 -0.164 0.183 0.707** 0.710** 0.726** 0.737** -0.272** 0.801** 1 0.093 
Vit Dm -0.001 0.119 -0.049 -0.150 0.140 0.005 0.011 0.037 0.000 -0.019 0.077 0.093 1 
6/3n 0.033 -0.012 -0.013 -0.005 0.075 -0.145 -0.109 -0.139 -0.022 0.067 -0.071 -0.094 -0.062 
AAo 0.175 0.009 0.082 0.113 0.029 -0.055 -0.032 -0.189 -0.104 0.111 -0.080 -0.097 -0.133 
EPAp 0.097 -0.063 0.005 0.050 -0.145 0.262** 0.184 0.257** 0.097 -0.146 0.154 0.187 -0.145 
DHAq 0.153 -0.025 -0.031 -0.013 -0.020 0.209* 0.179 0.164 0.059 -0.058 0.062 0.113 -0.037 
N-3 r 0.143 -0.055 -0.014 0.029 -0.054 0.254* 0.203* 0.215* 0.075 -0.085 0.085 0.142 -0.086 
PHQ s -0.145 -0.146 0.052 0.167 -0.055 -0.098 -0.092 -0.142 -0.093 0.163 -0.269** -0.184 -0.114 
Comt 0.191 0.025 0.075 0.061 0.152 0.173 0.139 0.057 0.072 -0.142 0.198* 0.131 -0.061 
Contu 0.072 0.046 0.033 0.003 0.079 0.062 0.042 0.073 0.007 -0.146 0.152 0.053 -0.035 
Challv -0.094 0.015 -0.107 -0.134 0.033 -0.028 -0.014 0.105 -0.041 -0.130 0.145 0.043 0.144 
Tot Rw 0.077 0.040 -0.002 -0.035 0.123 0.096 0.077 0.111 0.017 -0.196 0.232* 0.107 0.025 
Sit x -0.063 0.037 0.110 0.104 -0.158 -0.058 -0.047 -0.120 -0.099 -0.093 0.012 -0.081 -0.221* 
Big 5y  0.047 0.104 0.122 0.057 0.067 0.115 0.103 0.013 -0.066 -0.201* 0.167 0.065 0.131 
**Correlation significant at the p= 0.01 level *Correlation significant at the p= 0.05 level  aAge=age in years bHt=height in inches cWt=weight in pounds dBMI=Body 
Mass Index eDep=Number of deployments fPU=number of push-ups gPU S=push-up score hSU=number of sit-ups iSU S=sit-up score jR T=run time in seconds kRn S=run 
score lAPFT=APFT total score mVit D=vitamin d in ng/mL n6/3=Omega-6 to Omega-3 ratio percentage of phospholipid oAA=Arachidonic acid levels as a percentage of 
phospholipids pEPA=Eicosapentaenoic acid levels as a percentage of phospholipids qDHA= Docosahexaenoic acid levels as a percentage of phospholipids rN-3=Omega-
3 Index (EPA levels + DHA levels) sPHQ=Patient Health Questionnaire-9 scores tCom=Commitment score from Dispositional Resilience Scale-15 uCont=Control score  
from Dispositional Resilience Scale-15 vChall=Challenge score from  Dispositional Resilience Scale-15 wTot R=Total Resiliency Score from  Dispositional Resilience Scale-
15 xSit=Total weekly sitting time in minutes reported yBig 5=Resiliency based on Big 5 Questionnaire 
 
  
 39 
 
Table 3.  (continued)  
 6/3n AAo EPAp DHAq N-3 r PHQ s Comt Contu Challv Tot Rw Sit x Big 5y  
Agea 0.033 0.175 0.097 0.153 0.143 -0.145 0.191 0.072 -0.094 0.077 -0.063 0.047 
Htb -0.012 0.009 -0.063 -0.025 -0.055 -0.146 0.025 0.046 0.015 0.040 0.037 0.104 
Wtc -0.013 0.082 0.005 -0.031 -0.014 0.052 0.075 0.033 -0.107 -0.002 0.110 0.122 
BMId -0.005 0.113 0.050 -0.013 0.029 0.167 0.061 0.003 -0.134 -0.035 0.104 0.057 
Depe 0.075 0.029 -0.145 -0.020 -0.054 -0.055 0.152 0.079 0.033 0.123 -0.158 0.067 
PUf -0.145 -0.055 0.262** 0.209* 0.254* -0.098 0.173 0.062 -0.028 0.096 -0.058 0.115 
PU Sg -0.109 -0.032 0.184 0.179 0.203* -0.092 0.139 0.042 -0.014 0.077 -0.047 0.103 
SUh -0.139 -0.189 0.257** 0.164 0.215* -0.142 0.057 0.073 0.105 0.111 -0.120 0.013 
SU Si -0.022 -0.104 0.097 0.059 0.075 -0.093 0.072 0.007 -0.041 0.017 -0.099 -0.066 
R Tj 0.067 0.111 -0.146 -0.058 -0.085 0.163 -0.142 -0.146 -0.130 -0.196 -0.093 -0.201* 
Rn Sk -0.071 -0.080 0.154 0.062 0.085 -0.269** 0.198* 0.152 0.145 0.232* 0.012 0.167 
APFT l -0.094 -0.097 0.187 0.113 0.142 -0.184 0.131 0.053 0.043 0.107 -0.081 0.065 
Vit Dm -0.062 -0.133 -0.145 -0.037 -0.086 -0.114 -0.061 -0.035 0.144 0.025 -0.221* 0.131 
6/3n 1 -0.086 -0.320** -0.579** -0.590** -0.058 -0.050 -0.021 0.045 -0.011 -0.067 0.064 
AAo -0.086 1 0.141 0.441** 0.366** 0.075 -0.151 -0.103 -0.179 -0.205* 0.043 0.008 
EPAp -0.320** 0.141 1 0.523** 0.716** 0.013 0.083 0.017 -0.104 -0.004 0.070 0.119 
DHAq -0.579** 0.441** 0.523** 1 0.942** -0.125 0.104 0.082 -0.049 0.062 -0.032 0.032 
N-3 r -0.590** 0.366** 0.716** 0.942** 1 -0.064 0.100 0.088 -0.090 0.043 -0.018 0.035 
PHQ s -0.058 0.075 0.013 -0.125 -0.064 1 -0.495** -0.302** -0.337** -0.533** 0.138 -0.301** 
Comt -0.050 -0.151 0.083 0.104 0.100 -0.495** 1 0.528** 0.140 0.777** -0.312** 0.416** 
Contu -0.021 -0.103 0.017 0.082 0.088 -0.302** 0.528** 1 0.122 0.756** -0.016 0.263** 
Challv 0.045 -0.179 -0.104 -0.049 -0.090 -0.337** 0.140 0.122 1 0.607** -0.098 0.263** 
Tot Rw -0.011 -0.205* -0.004 0.062 0.043 -0.533** 0.777** 0.756** 0.607** 1 -0.202* 0.442** 
Sit x -0.067 0.043 0.070 -0.032 -0.018 0.138 -0.312** -0.016 -0.098 -0.202* 1 -0.142 
Big 5y  0.064 0.008 0.119 0.032 0.035 -0.301** 0.416** 0.263** 0.263** 0.442** -0.142 1 
**Correlation significant at the p= 0.01 level *Correlation significant at the p= 0.05 level  aAge=age in years bHt=height in inches cWt=weight in pounds dBMI=Body 
Mass Index eDep=Number of deployments fPU=number of push-ups gPU S=push-up score hSU=number of sit-ups iSU S=sit-up score jR T=run time in seconds kRn 
S=run score lAPFT=APFT total score mVit D=vitamin d in ng/mL n6/3=Omega-6 to Omega-3 ratio percentage of phospholipid oAA=Arachidonic acid levels as a 
percentage of phospholipids pEPA=  Eicosapentaenoic acid levels as a percentage of phospholipids qDHA= Docosahexaenoic acid levels as a percentage of 
phospholipids rN-3=Omega-3 Index (EPA levels + DHA levels) sPHQ=Patient Health Questionnaire-9 scores tCom=Commitment score from Dispositional Resilience 
Scale-15 uCont=Control score  from Dispositional Resilience Scale-15 vChall=Challenge score from  Dispositional Resilience Scale-15 wTot R=Total Resiliency Score 
from  Dispositional Resilience Scale-15 xSit=Total weekly sitting time in minutes reported yBig 5=Resiliency based on Big 5 Questionnaire 
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Categorical Analysis  
Table 4 presents a MANOVA with Depression Category as a factor.  We found 
that depression category had a significant Wilk’s Lambda effect (p=<0.001) on all 
variables. A post-hoc LSD analysis reveals Depression Category had a significant 
Between-Participants Effect on DRS commitment, control, challenge, and total 
resiliency score along with APFT run score. There is also a significant difference in the 
BMI of those in depression category 1 and 3.  Although significance was not obtained, 
we also found a trend in total fitness score and vitamin D and the depression categories. 
Based on our findings we accept H5. 
Table 5 presents a MANOVA with Vitamin D category as a factor. We found 
that Vitamin D category had an overall significant Wilk’s Lambda effect (p=<0.001) on 
all variables.  A post-hoc LSD analysis revealed there was a significant difference in 
DRS Challenge score in those that were deficient compared to both participants who 
were insufficient and sufficient.  There was no significant difference between 
Participants who were insufficient and those that were sufficient.  There was a 
significant difference in Run scores and total Army Physical Fitness Test scores in 
participants who were insufficient compared to those that were sufficient.  There was a 
significant difference in BMI in participants who were deficient compared to those who 
were insufficient and sufficient. Based on the findings we accept H6: Lower Vitamin D 
levels will be significantly related with higher resiliency and physical performance 
scores. 
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 Data are means ± standard deviations 
*Pairwise Comparisons 
0 represents p<0.05 difference from no depression, 1 represents p<0.05 from mild depression, 
2 represents p<0.05 from moderate depression, 3 represents p<0.05 difference from severe depression 
  
Table 4.  Between Participants Effects with Pairwise Comparison for Depression Level by Category. 
Variables None Mild Moderate Severe p-value 
N 55 32 7 6  
Commitment 10.98±2.42*1,2,3 8.49±2.83*0,2 5.86±2.91*0,1 6.83±4.12*0 0.000 
Control 12.98±2.15*1,2 11.69±3.03*0 9.86±4.30*0 10.83±5.53 0.015 
Challenge 9.27±2.97*3 8.58±3.25*3 7.86±2.61 5.17±4.58*0,1 0.023 
Total Resiliency 33.24±5.10*1,2,3 28.77±5.83*0,2,3 23.57±5.09*0,1 22.83±11.20*0,1 0.000 
PHQ-9 Total Score 1.78±1.45*1,2,3 6.00±1.39*0,2,3 10.71±0.76*0,1,3 21.33±2.66*0,1,2 0.000 
EPA  
(% total phospholipids) 
0.20±0.16 0.22±0.17 0.20±0.12 0.22±0.13 0.934 
DHA  
(% total phospholipids) 
1.17±0.42 1.25±0.45 1.00±0.19 0.93±0.52 0.264 
N6 to N3 ratio 8.82±4.07 7.79±1.92 8.14±0.99 8.23±1.59 0.558 
AA  
(% total phospholipids) 
0.20±0.06 0.22±0.08 0.24±0.05 0.18±0.08 0.158 
N-3 Index (EPA+DHA) 1.38±0.53 1.47±0.55 1.19±0.20 1.32±0.41 0.582 
Vit D (ng/mL) 29.42±8.81 28.93±8.74 24.29±9.69 25.00±6.07 0.357 
Push-ups 56.60±14.06 57.03±14.40 48.71±7.76 54.67±12.80 0.518 
Push-up  score 78.29±13.52 79.25±14.97 69.57±9.13 76.17±12.22 0.392 
Sit-ups 64.63±12.29 62.16±11.01 59.61±5.68 61.00±6.45 0.561 
Sit-up Score 79.18±14.43 75.95±14.98 72.21±8.58 75.83±7.99 0.525 
Run time (Seconds) 932.94±157.39 938.30±67.41 948.63±76.25 1022.83±77.56 0.434 
Run Score 70.42±16.38*3 70.78±13.51*3 67.42±14.00 51.00±16.41*0,1 0.032 
APFT total score 227.39±38.60 229.63±28.89 212.23±25.23 202.83±26.10 0.240 
BMI (kg/m2) 27.13±3.02 26.65±2.83*3 26.66±2.91 29.76±4.12*1 0.184 
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Data are means ± standard deviations 
*Pairwise Comparisons 
1 represents p<0.05 difference from deficient, 2 represents p<0.05 from insufficient, 
3 represents p<0.05 difference from sufficient 
  
Table 5.  Between-Participants Effects with Pairwise Comparison for Vitamin D Level by Category. 
Variables Deficient Insufficient Sufficient p-value 
N 16 39 45  
Commitment 9.75±3.91 9.14±2.85 9.89±3.16 .548 
Control 12.38±2.60 11.80±3.55 12.53±2.60 .527 
Challenge 7.00±3.20*2,3 9.07±2.90*1 9.00±3.14*3 .071 
Total Resiliency 29.13±7.08 30.01±7.12 31.42±6.18 .424 
PHQ-9 Total Score 5.94±7.11 5.41±5.24 4.16±4.24 .380 
EPA (% total phospholipids) 0.24±0.11 0.20±0.14 0.20±0.19 .675 
DHA (% total phospholipids) 1.15±0.52 1.16±0.39 1.19±0.43 .914 
N6 to N3 ratio 9.63±6.84 8.23±2.05 8.14±1.90 .262 
AA (% total phospholipids) 0.22±0.08 0.21±0.06 0.20±0.07 .616 
N-3 Index (EPA+DHA) 1.40±0.56 1.38±0.44 1.39±0.56 .995 
Vit D (ng/mL) 15.06±2.95*2,3 26.00±2.57*1,3 35.76±6.16*1,2 .000 
Push-ups 56.31±9.48 55.33±14.05 56.62±14.95 .911 
Push-up  score 79.00±8.95 77.21±14.66 78.02±14.48 .904 
Sit-ups 59.77±6.55 63.69±10.03 64.16±13.38 .395 
Sit-up Score 74.97±8.19 77.93±13.60 77.93±15.99 .743 
Run time (Seconds) 962.61±65.96 947.44±174.00 928.07±89.90 .601 
Run Score 66.34±14.43 64.61±15.90*3 74.11±15.13*2 .016 
APFT total score 220.30±24.12 218.11±37.61*3 233.91±33.84*2 .090 
BMI (kg/m2) 28.74±3.48*2,3 26.76±3.19*1 26.82±3.04*1 .084 
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 Table 6 presents a MANOVA with EPA as a factor. EPA had a significant 
Wilk’s Lambda effect (p=<0.001) on the variables.  EPA only had a significant 
between Participants effect on push-ups and push-up score. Based on our findings we 
accept H7: Higher EPA levels are significantly associated with higher physical 
performance scores and we reject H: Lower EPA levels are significantly associated 
with lower resiliency scores.   
Table 7 presents a MANOVA with DHA Quartiles as a factor. DHA Quartiles 
had a significant a significant Wilk’s Lambda effect (p=<0.001) on all the variables.  A 
post-hoc LSD analysis reveals there was a significant difference between sit-up scores 
for those who were in 3rd and 4th quartile. There was a significant difference between 
APFT total scores for those who were in the 3rd and 4th quartile.   There was also a trend 
towards lower depression scores (PHQ-9) as DHA quartiles increased.  Based on our 
finding we accept the hypothesis H9: Lower DHA is associated with lower physical 
performance scores and reject H10:Lower DHA levels are significantly associated with 
higher depression scores.  However because of observed trend, significance might be 
obtained with greater sample size.  
Table 8 presents a MANOVA with Arachidonic Acid (AA) as a factor. AA had a 
significant Wilk’s Lambda effect (p=<0.001) on the variables.   A post-hoc LSD analysis 
reveals AA had a significant between-participants effect on total resiliency scores. There 
was a significant difference in participants who were in the mean±SD and the 
participants who were 1 SD above the mean for commitment, challenge, and total 
resiliency Scores. There were also trends towards lower push-up, sit-up, run, and total 
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APFT scores as AA levels increased.  As well as a trend towards increased BMI.  Based 
on our findings we reject H11: Higher AA levels is associated with lower physical 
performance and H12: Higher AA levels are significantly associated with higher 
depression scores.  Although higher AA levels were not significantly associated with 
higher depression scores, it was associated with significantly decreased resiliency scores. 
Table 9 presents a MANOVA with BMI category.  BMI category did have a 
significant Wilk’s Lambda effect (p=<0.001) on the variables.  A post-hoc LSD analysis 
reveals there was a significant difference in vitamin D levels between those participants 
who had a BMI classification of overweight to those who were obese. There was a 
significant difference in sit-up scores between those who had a BMI classification as 
normal compared to those who were overweight and obese.  There were trends in 
increasing BMI classification and decreasing total resiliency scores and increasing 
depression scores (PHQ-9).  Based on our finding we accept H13: Higher BMI category 
is associated with significantly lower physical fitness scores but we reject H14: Higher 
BMI category is associated with higher depression scores. Although a trend was 
observed between higher BMI categories and increasing depression scores so a larger 
sample size might be needed.  
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Table 6.  Between-Participants Effects with Pairwise Comparison for EPA Levels 
Variables Normal High p-value 
N 88 12  
 Commitment 9.53±3.04 9.92±4.12 .693 
Control 12.34±2.77 11.33±4.36 .276 
Challenge 8.85±3.17 7.67±3.80 .240 
Total Resiliency 30.72±6.05 28.92±10.55 .384 
PHQ-9 Total Score 4.78±5.13 6.00±5.56 .447 
EPA (% total phospholipids) 0.16±0.07 0.53±0.24 .000 
DHA (% total phospholipids) 1.09±0.34 1.76±0.53 .000 
N6 to N3 ratio 8.77±3.25 5.76±1.70 .002 
AA (% total phospholipids) 0.20±0.06 0.24±0.09 .047 
N-3 Index (EPA+DHA) 1.27±0.35 2.26±0.65 .000 
Vit D (ng/mL) 29.24±8.71 24.25±7.92 .063 
Push-ups 54.73±12.98 65.92±15.77 .008 
Push-up  score 76.66±13.34 86.67±13.79 .017 
Sit-ups 62.67±10.65 67.69±14.92 .149 
Sit-up Score 77.27±13.66 78.87±16.92 .711 
Run time (Seconds) 943.51±129.03 923.81±110.91 .616 
Run Score 68.76±14.99 72.12±21.67 .493 
APFT total score 223.91±33.30 237.73±42.74 .196 
BMI (kg/m2) 27.16±3.29 26.69±2.67 .634 
Data are means ± standard deviations 
Normal=mean ± standard deviation, High= 1 standard deviation above the mean 
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Table 7.  Between-Participants Effects with Pairwise Comparison for DHA Quartiles. 
Variables 1st Quartile 2nd Quartile 3rd Quartile 4th Quartile p-value 
N 30 28 16 26  
Commitment 8.67±2.83 10.27±2.84 9.75±3.34 9.77±3.65 .266 
Control 11.57±2.47*3 12.29±3.26 13.50±2.22*1 12.12±3.53 .223 
Challenge 8.60±3.32 9.03±2.96 9.06±3.43 8.27±3.49 .815 
Total Resiliency 28.83±5.01 31.59±5.91 32.31±6.30 30.15±8.95 .282 
PHQ-9 Total Score 5.60±6.12 5.39±5.68 4.38±3.69 4.00±4.17 .631 
EPA (% total phospholipids) 0.16±0.09*4 0.16±0.08*4 0.17±0.08*4 0.32±0.25*1,2,3 .000 
DHA (% total phospholipids) 0.76±0.20*2,3,4 1.04±0.05*1,3,4 1.23±0.05*1,2,4 1.75±0.31*1,2,3 .000 
N6 to N3 ratio 10.62±4.85*2,3,4 8.26±0.93*1,4 7.93±0.89*1 6.31±1.62*1,2 .000 
AA (% total phospholipids) 0.17±0.05*3,4 0.20±0.06*4 0.23±0.06*1 0.24±0.07*1,2 .000 
N-3 Index (EPA+DHA) 0.96±0.20*2,3,4 1.20±0.11*1,3,4 1.41±0.11*1,2,4 2.07±0.47*1,2,3 .000 
Vit D (ng/mL) 29.11±9.32 28.70±8.40 28.50±8.73 28.12±8.87 .981 
Push-ups 53.27±12.60*4 57.54±13.47 49.31±11.00*4 61.88±14.83*1,3 .016 
Push-up  score 75.07±13.29*4 79.54±14.37 71.50±12.29*4 83.19±12.58*1,3 .026 
Sit-ups 61.57±10.00 64.15±9.66 58.89±9.45*4 66.98±14.20*3 .106 
Sit-up Score 76.40±12.24 78.98±12.32 70.84±16.21*4 81.11±15.33*3 .118 
Run time (Seconds) 957.27±81.84 936.45±81.44 914.82±249.38 943.81±102.39 .752 
Run Score 67.28±14.23 70.62±17.06 67.80±9.68 70.59±19.44 .808 
APFT total score 221.48±31.00 229.35±35.80 209.65±27.97*4 236.02±38.28*3 .087 
BMI (kg/m2) 26.77±3.19 27.55±4.02 27.36±2.64 26.85±2.67 .776 
Data are means ± standard deviations 
*Pairwise Comparisons 
1 represents p<0.05 from 1st Quartile, 2 represents p<0.05 from 2nd Quartile,  
3 represents p<0.05 difference from 3rd Quartile, 4 represents p<0.05 difference from 4th Quartile 
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Table 8.  Between-Participants Effects with Pairwise Comparison for Arachidonic Acid levels. 
Variables Low Normal High p-value 
N 17 63 20  
Commitment 10.00±1.97 9.88±3.19*3 8.25±3.64*2 .110 
Control 12.41±2.29 12.35±2.89 11.65±3.84 .637 
Challenge 8.65±3.26 9.20±3.08*3 7.20±3.49*2 .055 
Total Resiliency 31.06±4.02 31.44±6.32*3 27.10±8.61*2 .037 
PHQ-9 Total Score 5.12±6.36 4.57±5.04 5.90±4.54 .602 
EPA (% total phospholipids) 0.19±0.28 0.20±0.11 0.25±0.16 .458 
DHA (% total phospholipids) 0.96±0.46*3 1.10±0.35*3 1.57±0.40*1,2 .000 
N6 to N3 ratio 8.36±2.39 8.71±3.79 7.52±1.52 .366 
AA (% total phospholipids) 0.10±0.00*2,3 0.20±0.01*1,3 0.31±0.03*1,2 .000 
N-3 Index (EPA+DHA) 1.22±0.67*3 1.30±0.40*3 1.80±0.48*1,2 .000 
Vit D (ng/mL) 29.16±6.87 29.18±8.96 26.50±9.48 .477 
Push-ups 57.94±16.75 55.68±13.41 55.70±12.60 .830 
Push-up  score 78.94±14.87 77.57±14.33 77.85±11.08 .937 
Sit-ups 67.82±14.71 62.81±10.28 60.86±10.45 .150 
Sit-up Score 81.00±14.13 76.85±14.05 76.37±13.99 .519 
Run time (Seconds) 922.53±91.34 935.96±143.29 973.33±89.78 .418 
Run Score 72.41±13.75 68.95±16.01 67.07±17.24 .589 
APFT total score 232.71±32.41 224.99±36.61 221.34±30.33 .600 
BMI (kg/m2) 26.77±2.93 27.00±3.26 27.70±3.41 .637 
Data are means ± standard deviations 
*Pairwise Comparisons 
1 represents p<0.05 difference from 1 standard deviation below mean, 2 represents p<0.05 difference 
from mean± standard deviation, 3 represents p<0.05 difference from 1 standard deviation above mean  
Low=1 standard deviation below mean, Normal=mean ± standard deviation, High=1 standard deviation 
above mean 
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Table 9.  Between-Participants Effects with Pairwise Comparison for BMI Category. 
Variables Normal Overweight Obese p-value 
N 24 57 19  
Commitment 9.29±2.99 9.68±3.47 9.63±2.43 .881 
Control 12.75±2.23 11.88±3.40 12.58±2.48 .421 
Challenge 9.29±2.74 8.71±3.38 7.95±3.47 .409 
Total Resiliency 31.33±5.21 30.27±7.78 30.16±4.72 .787 
PHQ-9 Total Score 4.21±5.08 4.61±4.22 6.79±7.32 .209 
EPA (% total phospholipids) 0.18±0.23 0.22±0.14 0.20±0.09 .700 
DHA (% total phospholipids) 1.15±0.39 1.20±0.44 1.12±0.45 .742 
N6 to N3 ratio 8.88±2.06 7.89±1.90 9.37±6.29 .166 
AA (% total phospholipids) 0.19±0.07 0.21±0.06 0.21±0.07 .484 
N-3 Index (EPA+DHA) 1.34±0.56 1.43±0.50 1.34±0.49 .681 
Vit D (ng/mL) 29.58±6.70 29.56±9.74*3 24.68±6.82*2 .089 
Push-ups 59.04±14.87 54.51±13.49 57.00±13.06 .382 
Push-up  score 79.75±13.43 76.61±14.20 79.21±12.87 .579 
Sit-ups 70.04±13.18*2,3 60.95±10.19*1 61.68±8.54*1 .003 
Sit-up Score 84.00±13.36*2,3 75.51±13.76*1 75.05±13.62*1 .030 
Run time (Seconds) 916.63±98.58 939.25±149.76 977.83±61.62 .288 
Run Score 73.00±16.69 69.05±16.47 64.66±11.79 .231 
APFT total score 237.00±34.52 222.51±36.98 220.31±24.08 .174 
BMI (kg/m2) 23.13±1.30*2,3 27.16±1.37*1,3 31.95±1.76*1,2 .000 
Data are means ± standard deviations 
*Pairwise Comparisons 
1 represents p<0.05 from Normal, 2 represents p<0.05 from Overweight,  
3 represents p<0.05 difference from Obese 
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Table 10 presents a MANOVA using sitting time quartiles as a factor.  Sitting 
time quartiles had no significant Wilk’s Lambda effect (p=0.47) on the other variables.  
A post-hoc LSD analysis reveals there was a significant difference in Vitamin D levels 
and those in the lowest sitting quartile (1st) and those in the highest sitting quartile (4th).  
There was a significant difference in N3 to N6 ratios between those in the 1st quartile 
compared to those 2nd and 3rd quartiles for sitting.  There was a significant difference in 
Commitment scores and those in the 1st and 4th sitting quartiles as well as those in the 2nd 
and 4th quartiles. There were trends towards increased depression scores PHQ9 and 
decreased Total Resiliency scores as sitting quartiles increased.   Based on our findings 
we have to reject H15: Increased sitting time levels will be significantly associated with 
lower physical fitness scores and H16: Increased sitting time levels will be significantly 
associated with higher depression scores.  
Table 11 presents a MANOVA using total Army Physical Fitness Test (APFT) 
score quartiles as a factor. APFT score quartiles had a significant Wilk’s Lambda effect  
 (p=<0.001) on all other variables.  Post-hoc LSD analysis reveals a significant 
difference in PHQ-9 scores in those in 1st quartile compared to those in the 4th quartile.  
There was also a significant difference in Body Mass Index for those in the 1st, 2nd, and 
3rd quartile compared to those in the 4th quartile. The other significant differences 
between variables are expected as they serve as components of the Army Physical 
Fitness test.  Based on our finding we reject H17: Increased physical fitness will be 
significantly associated with higher resiliency scores but we accept H18: Increased 
physical fitness will be significantly associated with lower depression scores.  
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 Data are means ± standard deviations 
*Pairwise Comparisons 
1 represents p<0.05 from 1st Quartile, 2 represents p<0.05 from 2nd Quartile,  
3 represents p<0.05 difference from 3rd Quartile, 4 represents p<0.05 difference from 4th Quartile 
 
 
 
 
Table 10. Between-Participants Effects with Pairwise Comparison for Sitting Time (minutes) Quartiles. 
Variables 1st Quartile 2nd Quartile 3rd Quartile 4th Quartile p-value 
N 26 26 24 24  
Commitment 10.12±2.73*4 10.12±3.59*4 9.65±3.03 8.33±3.07*1,3 .155 
Control 12.08±2.74 12.88±2.88 12.55±3.23 11.33±3.10 .295 
Challenge 8.85±3.04 9.19±3.81 7.86±3.06 8.88±3.05 .518 
Total Resiliency 31.04±6.05 32.19±6.74 30.06±7.15 28.54±6.71 .265 
PHQ-9 Total Score 3.77±2.90 5.19±7.17 5.13±6.03 5.71±3.34 .587 
EPA (% total phospholipids) 0.16±0.10 0.23±0.22 0.20±0.10 0.23±0.19 .364 
DHA (% total phospholipids) 1.11±0.40 1.26±0.49 1.21±0.47 1.10±0.33 .478 
N6 to N3 ratio 9.74±5.30*2,3 7.85±2.19*1 7.93±1.72*1 8.06±2.05 .113 
AA (% total phospholipids) 0.22±0.07 0.20±0.06 0.21±0.07 0.20±0.08 .415 
N-3 Index (EPA+DHA) 1.27±0.44 1.53±0.58 1.42±0.52 1.34±0.47 .301 
Vit D (ng/mL) 31.96±9.65*4 28.16±9.28 27.58±8.60 26.61±6.42*1 .139 
Push-ups 56.85±13.94 57.65±14.53 55.17±12.61 54.42±14.38 .835 
Push-up  score 79.19±14.75 78.62±12.70 76.88±12.38 76.58±15.48 .887 
Sit-ups 62.73±10.47 65.40±13.68 63.26±10.51 61.56±10.27 .681 
Sit-up Score 78.92±13.02 76.79±16.90 78.06±13.24 76.00±12.97 .888 
Run time (Seconds) 970.76±71.80 935.84±96.30 944.39±97.19 911.59±204.86 .430 
Run Score 67.56±14.83 70.96±16.37 69.00±19.39 69.12±12.92 .899 
APFT total score 227.15±37.66 229.62±34.04 224.94±30.97 220.10±36.66 .802 
BMI (kg/m2) 26.57±3.07 27.05±3.27 27.46±3.46 27.38±3.20 .761 
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 Data are means ± standard deviations 
*Pairwise Comparisons 
1 represents p<0.05 from 1st Quartile, 2 represents p<0.05 from 2nd Quartile, 3 represents p<0.05 difference from 3rd 
Quartile, 4 represents p<0.05 difference from 4th Quartile 
  
Table 11.  Between-Participants Effects with Pairwise Comparison for Army Physical Fitness Test by Quartiles 
Variables 1st Quartile 2nd Quartile 3rd Quartile 4th Quartile p-value 
N 25 30 21 24  
Commitment 9.14±3.43 9.17±3.07 10.14±2.87 10.04±3.28 .545 
Control 12.21±3.54 12.07±3.07 12.05±2.87 12.58±2.52 .921 
Challenge 8.51±3.34 
 
8.50±3.10 8.81±3.31 9.08±3.46 .909 
Total Resiliency 29.86±8.70 29.73±6.42 31.00±5.46 31.71±5.77 .684 
PHQ-9 Total Score 6.40±6.87*4 5.23±4.80 4.43±5.07 3.46±3.06*1 .235 
EPA (% total phospholipids) 0.20±0.11 0.20±0.14 0.17±0.11 0.25±0.25 .464 
DHA (% total phospholipids) 1.12±0.46 1.11±0.31 1.17±0.51 1.30±0.44 .371 
N6 to N3 ratio 8.50±2.05 8.23±2.06 9.72±5.85*4 7.40±1.83*3 .119 
AA (% total phospholipids) 0.22±0.06 0.19±0.06 0.20±0.09 0.21±0.06 .530 
N-3 Index (EPA+DHA) 1.80±0.41 1.73±0.45 1.81±0.40 1.96±0.36 .251 
Vit D (ng/mL) 28.20±7.93 27.34±9.43 28.41±9.65 30.92±7.86 .505 
Push-ups  46.88±8.65*3,4 49.77±8.71*3,4 59.43±12.67*1,2,4 70.58±11.27*1,2,3 .000 
Push-up  score 67.84±9.83*3,4 72.03±9.17*3,4 82.38±12.99*1,2,4 91.63±9.29*1,2,3 .000 
Sit-ups 55.00±6.47*3,4 58.20±6.39*3,4 65.52±7.28*1,2,4 76.25±10.83*1,2,4 .000 
Sit-up Score 66.04±9.04*3,4 70.63±10.94*3,4 82.67±8.26*1,2,4 93.33±7.61*1,2,4 .000 
Run time (Seconds) 995.48±215.62*4 955.40±32.45*4 957.43±55.28*4 852.50±68.04*1,2,3 .000 
Run Score 51.70±12.67*2,3,4 68.45±5.52*1,4 70.10±9.09*1,4 87.42±11.01*1,2,3 .000 
APFT total score 182.88±19.72*2,3,4 217.00±4.95*1,3,4 235.14±9.45*1,2,4 272.38±14.02*1,2,3 .000 
BMI (kg/m2) 27.60±3.06*4 27.41±2.88*4 27.89±4.03*4 25.51±2.59*1,2,3 .043 
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Regression Equation Development 
Based on our MANOVA analyses in tables 12-14 we conducted a Binary 
Logistic Regression Analysis using Total Resiliency, BMI, Vitamin D, APFT total score, 
DHA, EPA, AA, and Sitting Total in order to predict whether a subject would be 
recommended to see Behavioral Health based on PHQ-9 cut-off score of ≥10 which has 
been used in previous research77.  Our model predicted whether a subject would have a 
PHQ-9 score associated with being recommended for Behavioral Health or not with 80% 
accuracy compared to the null hypothesis model of 13%.   The model has a sensitivity of 
76.9%, a specificity of 80.5%, and a positive likelihood ratio of 3.94 and a negative 
likelihood ratio of 0.287. We repeated the analysis without blood markers using Total 
Resiliency, BMI, APFT total score, and Sitting total in tables 15-17.  The non-blood 
marker model predicted whether a subject would have a PHQ-9 score of ≥10 with 79% 
accuracy.  The non-blood marker model has a 76.9% sensitivity, a specificity of 79.3%, 
and a positive likelihood ratio of 3.71 and a negative likelihood ratio of 0.291.  
Both models were then tested using subject data, and prediction rate matched 
SPSS data.   
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Table 12. Binary Logistic Regression Model Predicting Depression Levels Requiring Treatment 
Observed Predicted Actual False Positive False 
Negative 
Percentage 
Correct 
No Treatment Required 70 87 17  80.5 
Treatment Required 10 13  3 76.9 
Overall     80.0 
 
 
Table 13 Omnibus Test of Model Coefficients 
Step 1 Chi-square df p-value 
Step 32.604 8 .000 
Block 32.604 8 .000 
Model 32.604 8 .000 
 
 
 
Table 14  Binary Logistic Regression Model Variables in the Equation 
Variables B SE p-value 
Total Resiliency Score -.237 .080 .003 
BMI .127 .137 .353 
Vitamin D (ng/mL) -.044 .049 .376 
APFT total Score -.028 .017 .101 
DHA (% total phospholipids) -3.257 1.523 .032 
EPA (% total phospholipids) -.388 4.257 .927 
AA (% total phospholipids) -1.213 7.602 .873 
Sitting Total (minutes) .000494 .000331 .133 
Constant 10.648 6.152 .083 
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 Table 15  :Binary Logistic Regression Model Predicting Depression Levels Requiring Treatment Without Blood 
Markers 
Observed Predicted Actual False Positive False 
Negative 
Percentage 
Correct 
No Treatment Required 69 87 18  79.3 
Treatment Required 10 13  3 76.9 
Overall     79.0 
 
 
Table 16 :Omnibus Test of Model Coefficients Without Blood Markers 
Step 1 Chi-square df p-value 
Step 24.079 4 .000 
Block 24.079 4 .000 
Model 24.079 4 .000 
 
 
 
 
 
Table 17:Binary Logistic Regression Model Variables in the Equation Without Blood Markers 
Variables B SE p-value 
Total Resiliency Score -.193 .063 .002 
BMI .121 .113 .287 
APFT total Score -.021 .013 .098 
Sitting Total 
(minutes) 
.000382 .000272 .160 
Constant 3.850 5.545 .397 
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CHAPTER V 
SUMMARY 
A 2014 report by the Veterans Health Administration showed that suicide rates 
among male veterans under 30 increased by 44 percent from 2009-20118.  The majority 
of our population fits into this category with an age mean and standard deviation of 
26±5.6 with 63% having deployed at least once, and 27% having deployed multiple 
times.  Our finding of a 13% rate of depression based on PHQ-9 scores is similar to a 
study of 18,305 Army and National Guard Soldiers as the rate was 16% and 11% for the 
Army and National Guard Soldiers deployed to Iraq respectively12. It should be noted 
that 4 of 13 participants classified as behavioral health treatment recommend in our 
group reported not having deployed.    
Our mean PHQ-9 score of 4.93±5.17 was similar to the mean values that 
Breitbach et al.13 reported (4.5±5.9) in 955 male entry military personnel.   Our PHQ-9 
scores are slightly higher than those found by Luxton et al.14 in 6,427 military males pre 
and post deployment with a 2.26±3.31 pre deployment and a 3.62±4.37 post deployment.  
However, our PHQ-9 scores that were above 9 are similar to the 10.5% Luxton et al.14 
reported post deployment as ours are 9% when adjusted for those who have not 
deployed.  More recently Schaller and colleagues15 reported a PHQ-9 adjusted mean of 
7.2 based on results from 30,033 active service members but it should be noted that this 
group included females and members from other services.   
The mean score for commitment 9.57±3.16, control 12.22±2.99, challenge 
8.70±3.25, and total hardiness/resiliency in the DRS-15 is 30.50±6.69 were comparable 
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to the established norms for adult males by Bartone87 for commitment 10.19±2.47, 
control 10.27±2.06, challenge 9.86±2.30, and total hardiness/resiliency 30.34±5.2187.  
We found that there was a strong negative relationship (r=-0.533, p≤0.05) between DRS-
15 scores and PHQ-9 scores.  Similar findings were reported by Escolas et al.17 in 561 
service members with DRS-15 scores negatively associated (r=-0.39, p<0.001) with 
PTSD scores measured by Post Traumatic Stress Disorder Checklist Military Version 
(PCL-M).  The mean of our population (30.50±6.69) was slightly higher than reported 
by Escolas et al.17 of 28.69±6.16.  We also found a significant positive correlation 
between DRS-15 scores and run scores (r=0.232, p≤0.05) a negatively correlation with 
weekly sitting time (r=-0.202, p≤0.01), and APFT scores by quartiles and DRS-15 scores 
displayed a positive trend.   Our results demonstrate DRS-15 scores are associated with 
physical and mental health markers that were also reported by Taylor and colleagues18 in 
120 military men utilizing a Short Form Health Survey(SF-36)18.  DRS-15 scores were 
similar to our population with commitment (13.7±2.3), control (11.1±1.8), challenge 
(7.8±2.3), and DRS-15 total (32.6±4.6) along with age(24±3.3) of participants18.   
We also found a significant difference in mean BMI among participants who 
were classified as mildly depressed (26.65±2.83) versus those classified as severely 
depressed (29.76±4.12) and identified trends in reduced hardiness (DRS-15 scores) and 
increased depression scores (PHQ-9) as the BMI category went from normal to obese.  
Our findings are similar to a U.S. Department of Defense survey by Kress et al.56 of 
10,040 service members that found obesity as classified by BMI increased odds of 
depressive symptoms compared to normal weight service members. Our percentage of 
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subjects classified as normal (24%) was lower with overweight (57%) and  obese (19%) 
being higher than 37%, 53%, and 10% rates for normal, overweight, and obese in the 
7,567 active duty men reported in the study with 56.  Although we and Kress et al.56 
identified a relationship between BMI and depression, a study of 7,514 U.S. service 
members receiving psychiatric care with 85,940 healthy service members serving as 
controls reported no relationship was found between BMI and psychiatric disorder58.  
The reason for this contradiction is probably best explained by de Wit and associates59 
who reported the BMI and depression are not a linear association but rather a U-shaped 
curve.  A sample of 43,534 subjects age 18 to 99 in a general population was used to test 
the U-shaped curve and the authors found a very significant (p≤ 0.001) U-shaped 
association between BMI categories underweight, normal, overweight, and obese and 
depression but no significant association between depression and continuous BMI 59. 
Our mean for Vitamin D of 28.6±8.73ng/mL was slightly higher than the mean 
of 24.5±(0.5) SEM and 24.8±(0.5) SEM ng/mL in 495 U.S. service member suicide 
cases and 495 controls respectively reported by Umhau et al. 4. Our numbers are slightly 
lower than the 30±10 ng/mL reported by Wentz at al.47 in 314 Special Operation Forces 
(SOF) soldiers47.  In our study, 16 of the subjects classified as deficient (<20 ng/mL), 39 
as insufficient (20-30 ng/mL), and 45 as optimal (≥30 ng/mL) which is slightly lower 
than  the 30% vitamin D deficient reported by Umhau4 but similar to the over half  
insufficient to deficient levels reported by Wentz and colleagues47.  Our vitamin 
insufficiency rates are similar to that found in the general population as 37.27% of 3,100 
males age 18-39 were classified as mild to moderate hypovitaminosis D (25-70 nmol) 
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from NHANES III data 88.  For comparison that would be 6.29-22.01 ng/mL so the 
majority would fall into our deficient range of (<20ng/mL).   We observed a significant 
overall effect of vitamin D on all the variables and a significant difference in DRS 
control scores in those who were deficient (7.00±3.20) compared to those who were 
sufficient (9.00±3.14).  We also observed a negative trend in vitamin D levels and 
depression categories with no depression (29.42±8.81 ng/mL), mild (28.93±8.74 
ng/mL), moderate (24.29±9.69), and severe (25.00±6.07 ng/mL) depression levels.  This 
trend is in accordance with previous studies cited that have reported an inverse 
relationship between vitamin D levels and depression41, 42, 44, 45. 
Our findings are also supported by previous research by Ganji et al.43 who in a 
sample of 7,970 non-institutionalized US residents aged 15-39 found the odds ratio for 
having current depressive episodes was 1.85 (p=0.021) in those who were vitamin 
deficient compared to those who were not.   We also found a significant different in BMI 
in participants who were deficient (28.74±3.48) compared to those who were insufficient 
(26.76±3.19) and deficient (26.82±3.04).  This finding is similar to what Ganji et al.43 
reported that higher BMI was associated with increased risk of vitamin D deficiency.   
Analogous to our findings McGill and colleagues89 reported a modest inverse 
relationship between vitamin and BMI (r=-0.18, p=0.005), and multivariate regression 
analysis demonstrated a 0.74 nmol decrease in vitamin D per 1-point increase in BMI. 
Vitamin D was significantly associated with physical performance markers as 
with a significant difference in run scores in the insufficient group (64.61±15.90) 
compared to the sufficient group (74.11±15.13) and APFT scores for insufficient 
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(218.11±37.61) compared to those who were sufficient (233.91±33.84). A similar 
finding was reported by Ardestani et al.90 in a 200 person sample that vitamin D levels 
was positively correlated (r=0.29, p=0.0001) with cardiorespiratory fitness in healthy 
adults independent of BMI, age, and gender.   The correlation between vitamin D levels 
and physical performance was also reported by Koundourakis and colleagues51 in 67 
male soccer players in Greece to be significant for squat jump, counter movement jump, 
10 meter sprint, 20 meter sprint, and peak VO2 both pre and post a 6 week off season 
period with a mean vitamin D in pre 34.41±7.08 ng/mL and post 47.24±13.50 ng/mL. 
We found DHA levels by quartiles had a significant overall effect on all the 
variables.  Specifically DHA levels were associated with a significantly higher push-up 
scores 1st (75.07±13.29) to 4th quartile (83.19±12.58), sit-up scores 3rd (70.84±16.21) to 
4th  quartile (81.11±15.33), and total APFT scores 3rd (209.65±27.97)  to 4th quartile 
(236.02±38.28). There was a significant difference in DRS control scores for DHA 
levels in the 1st quartile (11.57±2.47) compared to those in the 3rd quartile (13.50±2.22) 
as well as a trend toward decreasing PHQ-9 scores as quartiles increased.  Our mean for 
DHA (1.17±0.426, % total phospholipids) was similar to the findings of Lewis et al.3 in 
a sample of 800 service members who committed suicide 1.14±0.45 and the 800 service 
members in the control group1.19±0.47.   
Our findings of higher trend towards PHQ-9 is supported by Lewis et al.3 
findings that  there was 62% increase in risk in suicide in subjects who are comparing 
low DHA levels of those below 1.75 to those above as the mean in our 4th quartile was 
1.75±0.31.  However, like Johnston et al.30 we found no significant association between 
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PHQ-9 scores and omega-3 fatty acid levels.  This may be because a larger sample size 
was needed to reach statistical significance. Our DHA levels were significantly lower 
than the values reported by Johnston (2.61±0.65 % total phospholipids).  
We did not find any association between omega-3 index scores and other 
pertinent variables which similar to findings by Johnston et al.30 also found it was not 
significantly associated with depression in a sample of 78 soldiers reporting to 
behavioral health treatment in Iraq 30.  Our omega-3 index (1.38±0.51) was significantly 
lower than those reported by Johnston (3.5±0.7)30.  This difference may be due to the 
different technique of assessing omega-3 index as Johnston and associates30 used dried 
blood spot testing instead of plasma. 
We also observed that arachidonic acid levels were associated with significantly 
decreased levels of resiliency.  Participants who had arachidonic acid within the 
mean±SD  had a DRS-15 score of 31.44±6.32 versus those who had levels above 1SD 
above the mean who had lower  DRS-15 score of 27.10±8.61.  This is similar to findings 
of Adams et al.91 who found higher arachidonic acid levels to eicosapentaenoic levels 
were significantly associated with increased severity of depression measured on a 
Hamilton Depression Rating Scale.   Higher arachidonic acid levels have been associated 
with increased depression following interferon treatment92.  Vaz and colleagues93 also 
reported that higher Arachidonic acid levels are associated with suicide risk and major 
depressive episodes in pregnant Brazilian women. 
Weekly sitting time was significantly associated with lower commitment scores 
for participants in the 1st quartile (10.12±2.73) versus participants in the 4th quartile 
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(8.33±3.07).  We also observed a trend towards higher depression scores as sitting time 
increased. Our findings were similar to Vallance et al.61 who reported increasing 
physical activity and decreasing sedentary time lowered the odds of depression in  a 
cross-sectional study of 2,862 adults61  Two Bosnian studies of 100 and 141 patients 
surveyed at a Family Medicine clinic using the IPAQ and PHQ-9 reported that an a 
association between higher physical activity and lower PHQ-9 stores and lower physical 
activity and higher PHQ-9 scores66, 67.  In a study of 346 Veterans being treated for 
PTSD, Davidson el al.65 reported that exercise was associated with fewer depressive 
symptoms along with better quality of sleep65.  A thorough meta-analysis of 30 trials by 
Rimer et al.68  reported that exercise may serve a potential treatment for depression as 
exercise reduced depressive symptoms in individuals depressed when compared to no 
exercise68 
In our investigation, we demonstrated that resiliency and physical fitness are 
strongly correlated with depression scores in soldiers based on the PHQ-9 assessment.   
The regression model we formulated serves both as a potential model for variables for a 
future intervention study and as a predictive tool to identify Soldiers who might be at 
risk for moderate to severe depression as classified by the PHQ-9. By improving 
resiliency in service members, we can potentially decrease the risk of mental health 
issues and by identifying them early we can potentially decrease the risk of a negative 
outcome.   
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Conclusion 
Napoleon famously stated “An Army marches on its stomach”94.  Results from 
this study suggests that one possible step in achieving better resiliency and health in 
soldiers is to is to adjust the US military diet to provide higher levels of eicosapentaenoic 
acid and docosahexaenoic acid more in line with diets found in traditional Mediterranean 
countries95.   The military is currently exploring ways to incorporate more omega-3 fatty 
acids into the food supply and combat the challenge of adequate shelf stability given the 
nature of the fatty acids to oxidize more rapidly than more saturated fatty acids33. 
Inadequate vitamin D levels is also an issue that needs to be addressed as 55 of 
the 100 soldiers in our study had insufficient to deficient levels.  Similar findings have 
been reported in the military population by Umhau et al.4as out of 900 of their subject 
samples 30% were vitamin d deficient and by Wentz et al as out of 314 Special 
Operation Forces(SOF) population, over half had insufficient to deficient levels4, 47.  A 
supplementation strategy of utilizing vitamin D3 would be the most effective and 
immediate strategy to correct insufficiencies and deficiencies96.  Physical fitness and 
body composition is also a concern given that 57% of our population is considered 
overweight, and 19% obese based on Body Mass Index numbers.  Although BMI does 
not take into account actual body composition, an overall rise overweight and obesity 
numbers in U.S. service members have been documented from 50.6% in 1995 to 60 % in 
2008 97.   
Our results indicate that lack of physical activity and fitness, high levels of AA 
and low levels of EPA, DHA, and vitamin D is associated with increased risk of 
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depressed mood and that use of a regression equation may be helpful in identifying 
soldiers at higher risk for possible intervention.  The regression equations we developed 
have the potential to allow medical providers a relatively effective tool for identifying 
those at risk.  The equation without blood markers could be immediately utilized as 
APFT scores and BMI measures are readily available for all soldiers with the only 
requirement being administering the 15 question DRS-15 and having soldiers report 
estimated week day and weekend sitting time over the last 7 days.  
Future Research 
More research is needed to determine if a cause and effect and/or dose-response 
relationship exists with our variables and depressive symptoms. However given our 
findings combined with previous research we can make a strong recommendation that 
Omega-3 fatty acid levels, vitamin D levels, and physical fitness be optimized through 
appropriate nutrition and training in order to improve and maintain soldier health and 
resiliency.  Future intervention trials should be conducted to explore the relationship 
between eicosapentaenoic acid, docosahexaenoic acid, arachidonic acid, vitamin D, 
sitting time, and physical fitness on mood and resiliency to determine if and where cause 
and effect relationships occur.  
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APPENDIX A 
CONSENT FORM 
Project Title:  The Relationship between Omega-3 fatty acids and Vitamin D blood levels 
and Physical Activity on Mood, Resiliency, and Physical Performance in Active Duty Soldiers. 
You are invited to take part in a research study being conducted by Dr. Richard 
Kreider, a researcher from Texas A&M University.  The information in this form is 
provided to help you decide whether or not to take part. If you decide to take part in 
the study, you will be asked to sign this consent form. If you decide you do not want 
to participate, there will be no penalty to you, and you will not lose any benefits you 
normally would have. 
Why Is This Study Being Done? 
The purpose of this study is to determine the relationship between omega-3 fatty acids, 
vitamin D, and physical activity and Soldier’s physical and cognitive performance. 
Why Am I Being Asked To Be In This Study?  
You are being asked to be in this study because you are a male between the ages of 18 and 
50 years of age on Active Duty. You will not be allowed to participant in this study if you 
are currently being treated for a behavioral health 
How Many People Will Be Asked To Be In This Study? 
Approximately 100 people will be invited to participate and complete this study locally. 
What Are the Alternatives to being in this study? 
The alternative to being in the study is not to participate. 
What Will I Be Asked To Do In This Study? 
You will be asked to fast and provide a blood sample, fill out a series of questionnaires 
and complete a standard Army Physical Fitness Test. You will also be asked to record all 
food and drinks you eat and drink on food record forms for four days (including one 
weekend day) prior to the first testing session/visit. Your participation in this study will 
last up to approximately three days and include three testing session (sessions lasting ~  
1.5 hours). Session 1 you will fill out baseline and psychometric data. Session 2 you will 
show up fasted and undergo a blood draw. You will then donate approximately 15 ml 
(about 3 teaspoons) of fasting blood from a vein in your arm according to standard 
procedures.  Session 3 you will conduct an Army Physical Fitness Test (APFT) and height 
and weight will be measured and recorded. 
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Day 1 Day 2 Day 3 
Recruitment Brief 
Consent Form 
Background Information 
IPAQ 
DRS-15 
Big 5 
Blood Draw 
Informed of time and 
location of APFT 
APFT 
Height and weight 
recorded 
You may be removed from the study by the investigator for these reasons: 
 You do not show up for the baseline T1 testing session/visit and the investigators
are unable to contact you to reschedule.  
 The investigators are unable to obtain a blood sample from you at either or both
testing sessions/visits. 
Are There Any Risks To Me? 
The things that you will be doing are greater than risks than you would come across in 
everyday life. Although the researchers have tried to avoid risks, you may feel that some 
questions/procedures that are asked of you will be stressful or upsetting. You do not have 
to answer anything you do not want to. You will donate approximately 2-3 droplets of 
blood during the initial familiarization/screening visit and then approximately 15 ml 
(about 3 teaspoon). The blood draws are the same as one’s you have experience when you 
joined the military and for the annual and pre and post deployment health screens. 
Are There Any Benefits To Me? 
The direct benefit to you participating in this study is to know more about your health and 
fitness status from the tests to be performed.  
Will There Be Any Costs To Me?  
Other than your time, there are no costs for taking part in the study. 
Will I Have To Pay Anything If I Get Hurt In This Study?   
If you suffer any injury as a result of taking part in this research study, you will receive 
the same medical treatment as you would with any military training activity. You should 
report any injury to Dr. Richard Kreider at 979-845-1333.  You will not give up any of 
your legal rights by signing this consent form. 
Side effects (injury) can happen in any research study. These effects may not be your fault 
or the fault of the researcher involved. Known side effects have been described in the “Are 
there any risks to me?” section of this consent form. However, side effects that are not 
currently known may happen and require care. You do not give up any of your legal rights 
by signing this form. 
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Will I Be Paid To Be In This Study? 
No.  
Will Information From This Study Be Kept Private? 
The records of this study will be kept private.  No identifiers linking you to this study will 
be included in any sort of report that might be published.  Research records will be stored 
securely and only Exercise & Sport Nutrition Laboratory staff will have access to the 
records. 
Information about you will be stored in locked file cabinets in a locked file room in an ID 
card swipe access controlled laboratory.  Computer files will be protected with a password.  
This consent form will be filed securely in an official area. 
People who have access to your information include the Principal Investigator and 
research study staff.  Representatives of regulatory agencies such as the Office of Human 
Research Protections (OHRP) and entities such as the Texas A&M University Human 
Participants Protection Program (HSPP) may access your records to make sure the study 
is being run correctly and that information is collected properly.  
The institution(s) where study procedures are being performed (Texas A&M University) 
may also see your information. However, any information that is sent to them will be 
coded with a number so that they cannot tell who you are.  Representatives from these 
entities can see information that has your name on it if they come to the study site to view 
records.  If there are any reports about this study, your name will not be in them.  
Information about you and related to this study will be kept confidential to the extent 
permitted or required by law.  
Who may I Contact for More Information? 
You may contact the Principal Investigator, Richard Kreider, PhD, to tell him about a 
concern or complaint about this research at 979-845-1333 or rkreider@hlkn.tamu.edu.  
You may also contact the Co-Investigator/Study coordinator Nicholas Barringer, at 254-
702-2772 or nicholasbarringer@hlkn.tamu.edu.   
For questions about your rights as a research participant; or if you have questions, 
complaints, or concerns about the research, you may call the Texas A&M University 
Human Participants Protection Program office at (979) 458-4067 or irb@tamu.edu.  
What if I Change My Mind About Participating? 
This research is voluntary and you have the choice whether or not to be in this study.  You may 
decide to not begin or to stop participating at any time.   If you choose not to be in this study 
or stop being in the study, there will be no effect on your military status or career. 
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STATEMENT OF CONSENT 
I agree to be in this study and know that I am not giving up any legal rights by signing 
this form.  The procedures, risks, and benefits have been explained to me, and my 
questions have been answered.  I know that new information about this research 
study will be provided to me as it becomes available and that the researcher will tell 
me if I must be removed from the study.   I can ask more questions if I want.  A copy 
of this entire consent form will be given to me. 
_______________________         ____________________________ 
Participant’s Signature Date 
___________________________________ __________________________ 
Printed Name Date 
INVESTIGATOR'S AFFIDAVIT: 
Either I have or my agent has carefully explained to the participant the nature of the above 
project. I hereby certify that to the best of my knowledge the person who signed this 
consent form was informed of the nature, demands, benefits, and risks involved in his/her 
participation. 
___________________________________ ____________________________ 
Signature of Presenter Date 
___________________________________             ____________________________ 
Printed Name Date 
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APPENDIX B 
FT.HOOD COVER SHEET 
Subject # 
MOS/AOC  
Time in Service 
Rank 
Number of Deployments 
78 
APPENDIX C
PATIENT HEALTH QUESTIONNAIRE 9 
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APPENDIX D
BIG FIVE QUESTIONNAIRE 
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APPENDIX E 
INTERNATIONAL PHYSICAL ACTIVITY QUESTIONNAIRE 
We are interested in finding out about the kinds of physical activities that people do as 
part of their everyday lives. The questions will ask you about the time you spent being 
physically active in the last 7 days. Please answer each question even if you do not 
consider yourself to be an active person. Please think about the activities you do at 
work, as part of your house and yard work, to get from place to place, and in your spare 
time for recreation, exercise or sport. 
Think about all the vigorous and moderate activities that you did in the last 7 days. 
Vigorous physical activities refer to activities that take hard physical effort and make 
you breathe much harder than normal. Moderate activities refer to activities that take 
moderate physical effort and make you breathe somewhat harder than normal. 
PART 1: JOB-RELATED PHYSICAL ACTIVITY 
The first section is about your work. This includes paid jobs, farming, volunteer work, 
course work, and any other unpaid work that you did outside your home. Do not include 
unpaid work you might do around your home, like housework, yard work, general 
maintenance, and caring for your family. These are asked in Part 3. 
1. Do you currently have a job or do any unpaid work outside your home?
Yes 
No Skip to PART 2: TRANSPORTATION 
The next questions are about all the physical activity you did in the last 7 days as part 
of your paid or unpaid work. This does not include traveling to and from work. 
2. During the last 7 days, on how many days did you do vigorous physical
activities like heavy lifting, digging, heavy construction, or climbing up stairs as 
part of your work? Think about only those physical activities that you did for at 
least 10 minutes at a time. 
_____ days per week 
No vigorous job-related physical activity Skip to question 4 
3. How much time did you usually spend on one of those days doing vigorous
physical activities as part of your work?
_____ hours per day
_____ minutes per day
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4. Again, think about only those physical activities that you did for at least 10
minutes at a time. During the last 7 days, on how many days did you do
moderate physical activities like carrying light loads as part of your work?
Please do not include walking.
_____ days per week
No moderate job-related physical activity Skip to question 6 
5. How much time did you usually spend on one of those days doing moderate
physical activities as part of your work?
_____ hours per day
_____ minutes per day
6. During the last 7 days, on how many days did you walk for at least 10 minutes
at a time as part of your work? Please do not count any walking you did to
travel to or from work.
_____ days per week
No job-related walking Skip to PART 2: TRANSPORTATION 
7. How much time did you usually spend on one of those days walking as part of
your work?
_____ hours per day
_____ minutes per day
PART 2: TRANSPORTATION PHYSICAL ACTIVITY 
These questions are about how you traveled from place to place, including to places 
like work, stores, movies, and so on. 
8. During the last 7 days, on how many days did you travel in a motor vehicle
like a train, bus, car, or tram?
_____ days per week
No traveling in a motor vehicle Skip to question 10 
9. How much time did you usually spend on one of those days traveling in a train,
bus, car, tram, or other kind of motor vehicle?
_____ hours per day
_____ minutes per day
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Now think only about the bicycling and walking you might have done to travel to and 
from work, to do errands, or to go from place to place. 
10. During the last 7 days, on how many days did you bicycle for at least 10
minutes at a time to go from place to place?
_____ days per week
No bicycling from place to place Skip to question 12 
11. How much time did you usually spend on one of those days to bicycle from
place to place?
_____ hours per day
_____ minutes per day
12. During the last 7 days, on how many days did you walk for at least 10 minutes
at a time to go from place to place?
_____ days per week
No walking from place to place Skip to PART 3: 
HOUSEWORK, HOUSE 
MAINTENANCE, AND 
CARING FOR FAMILY 
13. How much time did you usually spend on one of those days walking from place
to place?
_____ hours per day
_____ minutes per day
PART 3: HOUSEWORK, HOUSE MAINTENANCE, AND CARING FOR FAMILY 
This section is about some of the physical activities you might have done in the last 7 
days in and around your home, like housework, gardening, yard work, general 
maintenance work, and caring for your family. 
14. Think about only those physical activities that you did for at least 10 minutes at a
time. During the last 7 days, on how many days did you do vigorous physical
activities like heavy lifting, chopping wood, shoveling snow, or digging in the
garden or yard?
_____ days per week
No vigorous activity in garden or yard Skip to question 16 
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15. How much time did you usually spend on one of those days doing vigorous
physical activities in the garden or yard?
_____ hours per day
_____ minutes per day
16. Again, think about only those physical activities that you did for at least 10
minutes at a time. During the last 7 days, on how many days did you do
moderate activities like carrying light loads, sweeping, washing windows, and
raking in the garden or yard?
_____ days per week
No moderate activity in garden or yard Skip to question 18 
17. How much time did you usually spend on one of those days doing moderate
physical activities in the garden or yard?
_____ hours per day
_____ minutes per day
18. Once again, think about only those physical activities that you did for at least 10
minutes at a time. During the last 7 days, on how many days did you do
moderate activities like carrying light loads, washing windows, scrubbing floors
and sweeping inside your home?
_____ days per week
No moderate activity inside home Skip to PART 4: 
RECREATION, SPORT 
AND LEISURE-TIME 
PHYSICAL ACTIVITY 
19. How much time did you usually spend on one of those days doing moderate
physical activities inside your home?
_____ hours per day
_____ minutes per day
PART 4: RECREATION, SPORT, AND LEISURE-TIME PHYSICAL ACTIVITY 
This section is about all the physical activities that you did in the last 7 days solely for 
recreation, sport, exercise or leisure. Please do not include any activities you have 
already mentioned. 
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20. Not counting any walking you have already mentioned, during the last 7 days,
on how many days did you walk for at least 10 minutes at a time in your leisure
time?
_____ days per week
No walking in leisure time Skip to question 22 
21. How much time did you usually spend on one of those days walking in your
leisure time?
_____ hours per day
_____ minutes per day
22. Think about only those physical activities that you did for at least 10 minutes at a
time. During the last 7 days, on how many days did you do vigorous physical
activities like aerobics, running, fast bicycling, or fast swimming in your leisure
time?
_____ days per week
No vigorous activity in leisure time Skip to question 24 
23. How much time did you usually spend on one of those days doing vigorous
physical activities in your leisure time?
_____ hours per day
_____ minutes per day
24. Again, think about only those physical activities that you did for at least 10
minutes at a time. During the last 7 days, on how many days did you do
moderate physical activities like bicycling at a regular pace, swimming at a
regular pace, and doubles tennis in your leisure time?
_____ days per week
No moderate activity in leisure time Skip to PART 5: TIME 
SPENT SITTING 
25. How much time did you usually spend on one of those days doing moderate
physical activities in your leisure time?
_____ hours per day
_____ minutes per day
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PART 5: TIME SPENT SITTING 
The last questions are about the time you spend sitting while at work, at home, while 
doing course work and during leisure time. This may include time spent sitting at a 
desk, visiting friends, reading or sitting or lying down to watch television. Do not include 
any time spent sitting in a motor vehicle that you have already told me about. 
26. During the last 7 days, how much time did you usually spend sitting on a
weekday?
_____ hours per day
_____ minutes per day
27. During the last 7 days, how much time did you usually spend sitting on a
weekend day?
_____ hours per day
_____ minutes per day
This is the end of the questionnaire, thank you for participating. 
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APPENDIX F
ARMY PHYSICAL FITNESS SCORE CARD 
